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Abstract 
 
The work presented in this dissertation is a composite of experiments in the growth of 
gold nanoparticles with specific optical properties of interest. The goal is to synthesize 
these gold nanoparticles using soybean extract for not only shape control, but for 
propensity as a biocompatible delivery system. 
 
The optical properties of these nanoparticles has found great application in coloring glass 
during the Roman empire and, over the centuries, has grown into its own research field in 
applications of nanoparticulate materials. Many of the current functions include use in 
biological systems as biosensors and therapeutic applications, thus making 
biocompatibility a necessity. Current use of cetyltrimethylammonium bromide leads to 
rod-shaped gold nanoparticles, however, the stability of these gold nanoparticles does not 
endure for extended periods of time in aqueous media.  
 
In my research, two important components were found to be necessary for stable, 
anisotropic growth of gold nanoparticles. In the first experiments, it was found that 
bromide played a key role in shape control. Bromide exchange on the gold atoms led to 
specific packing of the growing crystals, allowing for two-dimensional growth of gold 
nanoparticles. It was also discerned that soybean lecithin contained ligands that blocked 
specific gold facets leading to prismatic gold nanoparticle growth. These gold nanoprisms 
give a near infrared plasmon absorption similar to that of rod-shaped gold nanoparticles. 
These gold nanoprisms are discovered to be extremely stable in aqueous media and 
remain soluble for extended periods of time, far longer than that of gold nanoparticles 
grown using cetyltrimethylammonium bromide. 
 
Since soy lecithin has a plethora of compounds present, it became necessary to discover 
which compound was responsible for the shape control of the gold nanoprisms in order to 
optimize the synthesis and allow for a maximum yield of the gold nanoprisms. Many of 
these components were identified by high performance liquid chromatography and liquid 
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chromatography–mass spectrometry. However, re-spike of these components into growth 
solutions did not enhance the growth of gold nanoprisms.  
 
Upon separating the shapes of the gold nanoparticles using gel electrophoresis, addition 
of KCN to the separated gold nanoparticles allowed us to extract the culpable ligands for 
shape control. Analysis of these ligands by mass spectrometry elucidated the identity of 
PA and upon re-spike of the PA into a growth solution of PC95, the growth of a near-
infrared plasmon absorption was seen.  
 
The stability of these gold nanoparticles was tested with and without the addition of 
decane thiol and it was concluded that addition of the thiol allowed for improved stability 
of the gold nanoparticles towards cyanide. It was determined that at a concentration of 2 
µM decanethiol, spherical gold nanoparticles remained stable to cyanide at the expense of 
the prismatic gold nanoparticles. However, at 5 µM decanethiol, both spherical and 
prismatic gold nanoparticles retained stability to cyanide in aqueous conditions. 
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Introduction 
1.1 – Gold nanoparticles in medicine 
 
Gold has been used since ancient times in a plethora of applications, from early uses in 
glass staining and as a monetary base, to more recent applications in microcomputing and 
medicine.1-18 The advancements of gold have been tracked as far back as 5000 B.C. for 
use in jewelry and art. As the properties of the metal were explored, gold became a 
popular use for potions and medicine.19 It was believed to contain magical qualities and 
its likeness to the sun made gold led to a reverent use of gold by priests, healers and 
shaman. Wiegleb documented some of the earliest uses of gold as medicine in Chinese 
culture as far back as 2500 B.C.20 another well documented account was of Moses 
burning the golden calf, preparing a potion from the ashes, and forcing the Children of 
Israel to “… drink of it”, is probably one of the earliest accounts of the practice of 
alchemy involving gold.21 The Taoist philosophers of ancient China used gold and silver 
coatings on medications to hopefully enhance the quality of their potions in 600 B.C.22,23 
Both Pliny the Elder and Dioscorides, in the first century A.D., record the use of gold as a 
medicinal agent.24 The great Persian medical schools, initiated by the Nestorian 
Christians, write that the pharmacist-physicians Yabir, Avicenna and Rhazes all 
supported the use of gold compounds as a panaceae. Yabir is attributed to have 
discovered the formulation of aqua-regia, capable of dissolving elemental gold. Medical 
knowledge from these Arab based sites of learning eventually spread into Europe and the 
British Isles. Philippus Aureleos Paracelsus, considered by some as the founder of 
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modern therapeutics, is reputed to have first used gold compounds in the treatment of 
tuberculosis and advocated the use of gold as a cure-all.  
 
It wasn’t until the early 19th century that the work of Andre-Jean Chrestien and Pierre 
Figuier, two professors at the University of Montpellier, laid the groundwork for modern 
use of gold compounds in medicine.25 Figuier was a pharmacist who put forth the 
formulations for gold salts such as gold sodium chloride. Chrestien then used this as a 
treatment of tuberculosis and syphilis in his 1811 publication, De La Methode 
Intraleptique. Soon after Chrestien’s work, the nobel laureate Dr. Robert Koch discovered 
that gold cyanide was bactericidal in vitro to tubercle bacilli.26 An erroneous but lucky 
assumption by Dr. Jacques Forestier that rheumatoid disease was an infectious disease 
analogous to tuberculosis led him to use gold thiopropanol sodium sulphonate on 15 
patients with inflammatory rheumatoid disease.27 The successful clinical experiment led 
researchers over the next 70 years to investigate both the beneficial and the toxic effects 
of anti-arthritic gold complexes.  
 
More recent advances in gold therapy have led to potential use of gold nanoparticles 
(GNPs) in cancer treatment.19,28-37 In many applications of GNPs in therapy, their optical 
properties are responsible for the therapeutic effects. GNP’s characteristic optical 
properties can be manipulated by controlling the shape of the GNP. For instance, in the 
case of rod shaped GNPs,29,31,37 two plasmon absorptions are seen in the UV-Visible 
spectrometer. The same can be seen in prismatic GNPs.38 Gold “nanoshells” have a long 
wavelength absorption.39 In these cases, the wavelength absorption in the near infrared 
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(NIR) emits heat as energy. Using this heat, it has been proposed that GNPs can be 
functionalized to target tumors and the tumors can be treated via hyperthermia.31,38,40,41 
Extensive research has been performed to synthesize biocompatible GNPs, which have 
absorption peaks in the NIR. These optical properties have been studied extensively for 
centuries. 
 
1.2 – Mechanisms in gold colloid synthesis 
 
Anisotropic noble metal nanoparticles have recently found great use in electronics, 
catalysis and medicinal applications.42-49 The optical and physical properties from their 
size and shape give these nanoparticles widespread applications in these areas. The 
synthetic groundwork of noble metal nanoparticles to control their size and shape has 
been studied extensively. Arguably, the largest challenge to these syntheses has been 
shape control, particularly for GNPs. Shape controlled synthesis of GNPs is dependent on 
many factors such as seed mediation, gold source and surface ligand selection. Many 
factors leading to shape control have been studied such as halide addition, silver assisted 
synthesis, temperature dependence and seed morphology. Seed-mediated synthesis in 
particular has led to many shapes such as rods, prisms, cubes, octahedra and plates. It was 
found that addition of ions added to these growth solutions can be used to adjust the 
shape control. 
 
Some of the first successful experiments done in shape control were performed in 1996 
when gold nanoparticles were grown by eletrodeposition in porous aluminum oxide. The 
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resulting rods showed interesting optical properties in the Visible-near-infrared spectra. 
Concurrent research found that electrochemical growth of gold nanorods was easily 
achieved using an oxidation/reduction method in a two-electrode cell (Pt/Au) when the 
reaction was done in an aqueous CTAB solution.50 A fairly uniform solution of rods 
formed and the aspect ratio could be manipulated by changing the reaction conditions. 
Further research into this method found that as the solution temperature increased, the 
aspect ratio decreased, giving another method of manipulating shape and size of gold 
nanorods.51 
 
Although the electrochemical method was effective, new research went into finding a 
synthetic method to control shape. A seed-mediated synthesis was found to be the most 
effective method of shape control of GNPs.52 For anisotropic shapes from the more 
ordinary rod and prismatic shaped nanoparticles to the more exotic periwinkle and star-
shaped nanoparticles, seed-mediated methods are employed.44,53,54 The morphology of 
the seed was found to be important in the resulting GNP growth.55 It has been found that 
different morphologies of rod-shaped GNPs resulted depending on if the seed was single 
crystalline or multiply twinned. Seeds with pentatwinned morphology result in twinned 
gold nanorods as well as twinned bipyramidal nanoparticles while the single crystalline 
seeds result in single crystalline gold nanorods.55,56 
 
Seed size has also been shown to affect GNP morphology.57 The seeds are believed to 
provide nucleation points for growth of larger particles and the reactivity of smaller 
particles allows for larger growth effects. The smaller seeds also allow for more 
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variability in growth features such as concavity and available facets. Larger seeds (>15 
nm) contain larger facets for gold deposition to occur resulting in poor shape control.  
 
Ion doping also has been found to affect GNP morphology. Multiple groups have studied 
the catalytic effect of silver ions in the growth solution originally investigated by El-
Sayed.55,56,58 This was reported as an underpotential deposition of Ag(I) which leads a 
strong influence of ordering the ions on the more open (110) face of the crystal. Iodide 
spiking has also been found to change the resulting crystal shape in GNPs.38,59,60,61,62 As 
discussed, silver adsorbs selectively to {110} Au facets by underpotential deposition 
(UPD) and inhibits Au deposition on those surfaces but allows Au deposition on {100} 
and {111} surfaces, leading to nanorod growth in the [100] direction. However, iodide 
has a higher propensity to Au {111} surfaces and prevents nanorod growth by blocking 
that surface. By manipulating the concentration of iodode present in growth solutions, 
prism, dogbone and ellipsoid shapes can result.61,62  
 
Other factors affecting shape control of GNPs can be pH63 and heat.62 Varying the pH of 
a growth solution has been found to affect micelle growth. At low pH, ionic moieties are 
protonated and change the intermolecular binding energies causing a different growth 
pattern. Also, a higher pH results in negative charge building on the GNP surface, 
thereby increasing electrostatic repulsion. As a result, nanoparticle fusion is efficiently 
inhibited giving a single modal growth of GNPs. pH effects lead to shapes such as 
needle-like nanoparticles, spherical nanoparticles and nanorods. As to heat effects, heat 
has been attributed to increased width of gold nanorods. Heating growth solutions to 100 
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oC found that the resulting rods had reduced aspect ratios. The length did not decrease 
noticeably in the nanorod solutions, however widths increased significantly. Varying the 
heating times and growth solution concentrations result in shapes such as nanocubes and 
nanorods. 
 
Surface modification of gold nanoparticles has been studied extensively.64-68 In the use of 
GNPs for medicinal applications, cytotoxicity is a large concern for in vivo functionality. 
Much focus has been placed on surface ligands and surface exchange is a popular form of 
modification. Phospholipids and thiols have been exchanged for CTAB surface ligands in 
many cases and found to reduce cytotoxicity in cell uptake. Ligand exchanges are 
achieved by centrifuging the GNPs and then redissolving the GNPs in a solution of the 
alternate ligand. This modification has been found to lower the cytotoxicity allowing for 
the potential to be used in drug delivery and photothermal therapy. 
 
Photothermal therapy has been employed for phase one clinical trials on dogs with cancer 
in Ohio. The use of hyperthermia to treat cancer is well-established including 
radiofrequency ablation, laser-induced photodynamic therapy, and ultrasound 
ablation.39,41,69,70 Gold nanorods coated with polyethyleneglycol polymers take advantage 
of NIR light by producing heat. Surface-Enhanced, Resonant Raman Scattering (SERRS) 
gives enhanced activity and these SERS-coded NRs are highly stable, are detectable 
down to extremely low concentrations. In vivo, SERS-coded nanorods are trapped in 
tumor blood vessels following intravenous injection permitting the heating of the 
nanorods to high temperatures within the tumor using an externally applied NIR diode 
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laser. Solid dog tumors have shown significant reduction in tumor size with little side 
effects using this method. 
 
1.3 – History of gold colloids into the 20th century 
 
Even before the nanoscale was realized. It was discovered that transition metal 
nanoparticles less than 100 nm in size absorb characteristic colors when they interact 
with electromagnetic energy. More recently, it has been discovered that the size and 
shape of nanoparticles is important in the interaction with light. Due to these interactions, 
GNPs have found uses in drug delivery and plasmonic photothermal therapy.71,72 
However, there are still some problems associated with the stability and biocompatibility 
of these nanoparticles in solution. 
 
The history of GNPs ranges back to Egypt and China in the 5th century B.C., where it was 
found that gold salts added to molten glass produced a “ruby red” color in the glass. It 
was also used as a colorant on ceramics, which gave a red tinge to the materials. Wilhelm 
Ostwald studied the ancient processes and stated,2 “This colloidal gold was prepared even 
in the days of the alchemists by the reduction of gold salts by all kinds of organic 
substances, including urine.” These gold colloids gave characteristic colors of red and 
purple and eventually led to large-scale use in the ancient societies for decorative 
purposes.   
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Colloidal gold became especially popular when it started being used in the staining of 
glass. The ruby-red color common with colloidal gold gave a vivid stain to glass and was 
very popular among churches and wealthy families. Of the most famous examples is the 
Lycurgus Cup. Roman artists crafted it in the 4th century AD.4 The cup contains a 
dichroic glass made up of silver and gold nanoparticles. The glass reflects green and 
transmits red making it “the most spectacular glass of the period, fittingly decorated, 
which we know to have existed".5 
 
Ayurveda in the Hindu culture was the first noted use of gold salts in the medicinal 
system.3,73 Bhasmas are metallic/mineral preparations combined with herbal extracts 
from decoctions. They have been widely used to treat a variety of maladies since the 7th 
century A.D. These treatments are claimed to be biologically produced nanoparticles and 
many of the desired properties of Bhasmas steered away from the metallic characteristics 
and aimed more towards the plant properties. It is stated, “Bhasma must be Nischandra 
(lusterless) before therapeutic application. Chandratva (luster) is a character of metal. 
After proper incineration, luster of metal should not remain.” Preparing these potions in 
this way, the ultimate goal of biocompatibility was inadvertently realized. “Bhasma must 
be Sukshma [fine or smooth], so that it can be absorbed by the body easily.” Also, 
“Slakshna Bhasma can be absorbed and assimilated in the body without producing any 
irritation to mucous membrane of gastrointestinal tract.”73 The red colloidal solutions   
	   9	  
 
Figure 1.1 – The Lycurgus Cup showing the dicroic nature of the glass. The 300 ppm silver 
nanoparticles reflect an opaque green (seen right) while the 50 ppm gold nanoparticles give a 
translucent red color when light is shined through the glass (seen left).4,74 
  
believed to cure everything from a simple cough to tuberculosis, and the specific color of 
the solutions was important in determining if the solutions were prepared properly and 
therefore biocompatible.75 
 
It wasn’t until the 1670’s that reproducible color could be produced. German alchemist 
Johann Kunckel found evidence in experiments performed by Johann Glauber that salts 
of gold chloride added to glass could give the ruby-red color to glass.6 Kunckel used this 
information to produce many works of gold ruby glass. It was found that charging the 
glass with a solution of gold in aqua regia gives an opaque, grey glass, which upon 
annealing, produces a ruby-red translucent glass7 (Figure 2).  The science of making red 
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glass thus became experimentally possible, but it wasn’t for another two centuries that the 
science behind the red color began to be explained. 
 
 
Figure 1.2 – Examples of ruby-red glassware made by Kunckel’s. Included is a covered goblet 
sold from Kunckel’s shop prior to 1691. It is now on display in Hamburg. These are some of the 
few surviving pieces from the alchemist’s works.6,7 
 
Michael Faraday was the first to use gold colloids for scientific purposes.8 In the 19th 
century, Faraday developed a method of using aqueous gold chloride and phosphorus in 
CS2 to synthesize a variety of solutions of GNPs. These nanoparticles ranged from 2 – 
100 nm in size and had a variety of colors depending on the pressure applied to them 
after synthesis. Faraday thus illustrated that the ruby glass was colored so, because of the 
presence of finely dispersed gold particles. Faraday did note that in these methods, the 
nanoparticles tended to aggregate when electrolytes and non-polar surfactants were 
introduced to the solution. His hypothesis that the colors of gold solutions were in fact 
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colloids was further supported when he carried out reactions to prove that ‘Purple of 
Cassius’ could be obtained by adding tin chloride to gold sol. Though colloids had been 
produced for centuries, it was Faraday’s methods that first connected modern science to 
GNPs. 
 
Other chemists also contributed to the evolution of nanoparticulate chemistry concerning 
gold. When Zsigmondy began his investigations into the color of ruby glass and 
formulated a method for preparing colloidal gold (by reducing a dilute, slightly alkaline 
solution of gold chloride with boiling formaldehyde), he was unaware of Faraday’s work. 
After discovering Faraday’s methods, especially reduction using phosphorus, he 
combined both the synthetic techniques to arrive at a two-step synthesis method, referred 
to as the seed-mediated method today.9,10 Zsigmondy first described color differences 
seen when using polarized light parallel and perpendicular to anisotropic particles.11 He 
observed that GNP films on gelatin gave rise to two results: 1) When particles were 
observed perpendicular to the longer diameter, then the transmitted light is red and 
diffracted green; 2) On the contrary, if the vibrations are parallel to the longer diameter, 
then the transmitted light is blue and the diffracted light yellow or brown. These optical 
properties led to some of the current technologies we use today. 
 
Ostwald’s contribution to the study presented many key theoretical principles and in his 
research he demonstrated the importance of salinity on the growth process of the 
nanoparticles. He stated, “In order to obtain [colloidal gold] by condensation, I begin 
with a molecularly or ionically dispersed solution of gold chloride to which sodium 
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bicarbonate has been added until neutral to litmus. I need now to reduce the gold chloride 
to metallic gold, but this must be done in such a way that metallic gold remains so highly 
dispersed as not to exceed colloidal dimensions.” He goes on further to explain, “As you 
know, gold chloride can be reduced by many different kind of substances, especially 
organic ones. You need but dip your finger into the solution when it becomes stained 
with bluish violet by the colloid gold produced through the reducing action of the organic 
substances contained in the skin.” In this, Ostwald’s remarks demonstrate that the size is 
key in keeping particles dispersed. From this, we get the term “Ostwald ripening,” 
referring to the equilibria growth of nanoparticles resulting from the surrounding 
envoironment. 
 
It wasn’t until 1951 that the stability of GNPs began to be studied. John Turkevich’s 
work on synthesis of gold colloids using sodium citrate found that GNPs were stable for 
extremely long periods of time, and also produced GNPs which were fairly mono-
disperse by the time period’s standard.76,77 By the end of the 20th century, many new 
methods were being developed in synthesizing GNPs. In 1973, Gerrit Frens refined work 
performed by Turkevich in 1951 to give better size control to GNPs using the citrate 
synthesis. Wilcoxon developed a two-phase method for synthesis of nanoparticles with 
various polar and non-polar ligands.78 Brust used hydrophobic thiols in 1993 to 
synthesize hydrophobic nanoparticles, which are more stabile to aggregation.79  
 
More recently, new discoveries in GNP research have led to size and shape control. In 
short, Michael Natan developed a seed mediated approach to GNP growth based on 
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patent literature,80 which led to a more monodisperse synthesis of nanoparticles.81 Chris 
Wang’s group realized electrochemical methods in synthesizing rod shaped GNPs and 
Catherine Murphy and Mustafa El-Sayed used the seed-mediated idea as a basis to 
develop a chemical synthesis of shape controlled GNPs.52 However, stability of the 
nanoparticles in solution during a shape controlled synthesis still remains a problem. For 
the purpose of medicinal use, it is important that these GNPs remain stabile and it has 
been proposed that natural extracts could be of use in synthesizing anisotropic GNPs. 
 
1.4 – Short history of Soybeans into the 20th Century 
 
At the same time that gold was being used in Egyptian art and jewelry, China was 
developing another essential resource. Soybeans have been important throughout history, 
from farming to nutrition, and even to drug delivery.82,83,84 Soybeans have been a crucial 
tool used in the rotation of food crops, thus providing a method of fixing nitrogen in the 
soil. They’ve also served as a source of protein in feed for livestock. And since the 
discovery of fermenting, soy has been used as a staple in a multitude of different cuisines 
such as Japanese (miso, edamame), Chinese (soy sauce) and has received huge accolades 
in the vegetarian diet (tofu, tempeh, soy milk, soy cheese, etc.). Soybeans have even been 
used to make milk substitutes for the lactose intolerant.  
 
Soybeans have been around since ancient times. The first records of soybeans were 
written in 2853 B.C. when the Chinese Emperor Shennong proclaimed soy a sacred 
plant.85 It was slowly introduced to other Asian cultures such as Korea and Japan over the 
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next millennium and became a key ingredient in the local cuisine. Preserved soybeans 
have been found in Korea and date back to 1000 B.C. The beans were used to produce 
tofu and soy milk and used on a large scale by the orient. These legumes were consumed 
in the typical diet of the Asian population, however, they did not make their way to other 
subcontinents until the 18th century.  
 
Around the beginning of the 1st century, fermentation of the soybean was discovered and 
allowed for removal of phytoestrogens found in raw soybeans.85 This lead to the 
introduction of soy sauce and miso into average households and a new revolution of food 
was introduced to the world. Due to its popularity and the development of trade routes, 
the soybean soon spread to the rest of the Asian continent. However, the soybean was not 
introduced to Europe until 1739 when the first plants were cultivated in France. It was 
reported that Benjamin Franklin sent seeds of the bean to the Pennsylvania colonies of 
the New World to be planted by his botanist friend, John Bartram, in 1770. 
 
Soybeans have become a huge influence in all nations for food stocks and have been 
attributed to longevity of life and health.86 The Okinawa Centenarian Study states, 
“Okinawan elders eat an average of two servings of flavonoid-rich soy products per day.” 
They also report, “This enormously reduced cancer risk arises in part, the study’s authors 
say, from the Okinawans large consumption of isoflavones from soy. This is an important 
finding.” “Okinawans are at extremely low risk for hormone–dependent cancers, 
including cancers of the breast, prostate, ovaries, and colon. Compared to North 
Americans, they have a staggering 80 percent less breast cancer and prostate cancer, and 
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less than half the ovarian cancer and colon cancer.” 
 
In modern times, the soybean has remained a key food staple in the world diet, however, 
it has also evolved into a scientific field. Many books and journals have been introduced 
solely dedicated to soybeans and the health and chemical characteristics of the legume. 
The chemical content of the soybean makes for a wide variety of topics to be discussed. 
The phytoestrogens, isoflavins and Omega-3 fatty acids have made it a hot topic in 
medical journals and the phospholipids it contains are a huge source of scientific study 
due to their ability to assemble into multilayered isoforms.87-92 The liposomal nature of 
the phospholipids allows scientists to obtain a cheap source mimicking lipid bilayers, the 
backbone of all biological cells and therefore, provide a potential biocompatible element.   
 
More recently, soybean proteins and phospholipids have been proposed in drug delivery 
systems.93,94,95 Use of lipid emulsions and hydrolyzed polymeric lipids have shown great 
promise in drug delivery. In every case, the delivery systems were tested for cytotoxicity 
and biocompatibility and found that in many cases, the natural product was completely 
safe for use in human physiology.93-96 Even more research has been performed to test the 
biocompatibility of these substances when encapsulating anisotropic GNPs. The optical 
properties of anisoptropic transition metal nanoparticles, especially gold and silver, has 
become of considerable interest when being used in biosensors and therapeutics, and for 
the use in biological systems, the gold and silver nanoparticles must be biologically 
adaptable.  
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Theory of Optical Properties of Gold Nanoparticles 
2.1 – Physical properties of Gold Nanoparticles 
 
The study of nanotechnology is highly dependent on the ability to create and manipulate 
materials in the range of 1 – 100 nm.97-109 This will lead to smaller, faster, cheaper 
materials for data storage, energy manipulation and medical devices in which the devices 
fabricated will approach the size of individual molecules.  The nanoscale is put into 
context in Figure 2.1, which shows the size change from a soccer ball down to a 
buckyball. In downsizing materials to the nanoscale, it has been discovered that the 
nanoscale properties of materials are sometimes extremely different from their bulk 
counterparts, giving interesting properties. 
 
 
Figure 2.1 – Contextual visual scaling down from the size of a soccer ball, through biological oligomers to 
nanomaterials such as a buckyball.110 
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Two principal driving forces behind the differing properties are an increase in the surface 
area of the material and the size-dependent properties, which dominate in the nanoscale. 
This affects the chemical reactivity, electrical, optical and thermal properties of the 
material. This can lead to promising uses for the nanomaterials such as catalysis, 
photovoltaic and medicinal uses. Gold for example is being studied for medicinal 
purposes due to its non-toxic nature and its change in reactivity from bulk to the highly 
reactive nanoscale.16,17,18 
 
2.2 – Gold Chemistry 
 
Gold has been thoroughly studied by scientists in order to understand the inert nature of 
the metal. It is important to understand the redox potentials of gold in order to explain its 
nobility. In order for any reaction to occur with gold, it first must be oxidized, 
Au  Au+aq + e-      2.1 
The reduction potential can be explained using the Nernst equation: 
 
 
where R is the gas constant, F the Faraday constant, T the absolute temperature and E° 
the standard electrode potential for the reaction (~ 1.7 V). Solving this gives 
E = 1.7 + 0.059 log10 [Au+] 
 
Gold has two oxidation states, the +1 and the +3 so solving for the +3 state gives 
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Au  Au3+aq + 3e-     2.2 
E = 1.50 + 0.0197 log10 [Au3+] 
Gold can also react with its environment. 
Au + 3H2O Au(OH)3 + 3H+ + 3e- 
E = 1.46 – 0.059 pH 
Further reaction gives 
Au(OH)3 AuO2 + H2O + H+ + e- 
E = 2.63 – 0.059 pH 
This, of course, can only happen if strong oxidants are present. To discuss the 
equilibrium between auric hydroxide and auric ions,111 a constant concentration is used. 
At [Au3+] = 10-4 M  
Au3+ + 3H2O Au(OH)3 + 3H+ 
 
Water’s stability also limits the electrochemistry driven by a voltage to oxidize to oxygen 
or reduce to hydrogen. This is shown by 
2H2O O2 + 4H+ + 4e- 
E = 1.229 – 0.059 pH 
or 
2H2O + 2e- 2OH- + H2 
E = 0.0017 – 0.059 pH 
 
It can be concluded that gold cannot be oxidized in dissolved oxygen with strong acids or 
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alkalis. Gold is the only element with this property giving more credit to its nobility. 
 
Gold dissolves in solution containing gold-specific ligands and an oxidizing agent, 
however these alone are not adequate. For example, gold does not dissolve in HCl or 
HNO3 alone, but in aqua regia, HAuCl4 is formed. Similarly, CN- needs oxygen from air 
or an oxidizing liquid to dissolve gold metal.112 A generalization is written as 
Au + 2CN-  [AuCN2]+ + e- 
which is further oxidized to AuIII by 
[AuCN2]+ + 2CN-  [AuCN4]3+ + 2e- 
Returning to the standard potentials, it is seen that good ligands with high K values give a 
low E° value according to the Nernst equation. It is seen that the ionic gold atoms cannot 
exist in solution free, but form complexes with the ligands present. If water is the only 
available ligand, it can form the aqua ions form,  and . Substituting 
chloride in gives 
 
 
2.3 – GoldIII complexes 
 
The complex HAuCl4 was shown to be made using aqua regia. Substituting HBr for HCl 
similarly gives HAuBr4. Evaporation of the solution, followed by washing with the 
respective halogenated acids generates hydrated forms of the molecule (i.e. – HAuBr4 • 
xH2O). The important aspect of this is that the gold complexes of these compunds have a 
low-spin 5d8 electron configuration, giving a four coordinate square planar stereocenter. 
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This allows reaction with the gold center more easily. This can also be seen in other 
group 10 and group 11 metals such as platinum. 
 
This leads to the interesting optical properties. Figure 2.2 shows the molecular orbital 
diagram for a square planar AuIII complex113 
 
Figure 2.2 – Molecular Orbital diagram for square-planar AuIII complex114 
 
AuIII has a d8 electronic configuration in which all of the 5d orbitals are double occupied 
except the . The energy differences between the occupied d orbitals give weak 
ligand to field transitions at low energy. This can be seen in Figure 2.3 showing the 
absorption spectra of HAuCl4 and HAuBr4 (both at 10-4 M in methanol). The difference in 
intensity shows that the extinction coefficients are not isolated to the metal d shell, but 
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correspond to the ligand to metal charge transition.115 This leads to an increased 
absorption at a longer wavelength for the HAuBr4. The shifted absorbance is due to a 
lower ionization potential over the chloro-derivative as it gets easier to oxidize the halide. 
 
 
Figure 2.3 – Absorption spectra of HAuCl4 (green trace) and HAuBr4 (red trace). Both have concentrations 
of 10-5 M and are dissolved in methanol.116 
 
2.4 – Colloids 
 
Metal colloids are an example of a lyophobic colloid (as opposed as lyophilic colloids 
like proteins). These colloids are thermodynamically unstable unless they are either 
kinetically stabilized by a charge (electrostatic stabilization) or separated by adsorbed 
ligands preventing their approach to each other (steric stabilization). This prevents 
aggregation of the colloids leading to coagulation of the particles out of solution. It is the 
steric stabilization that is the most common form of stabilization when using metal 
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nanoparticles. 
 
Addition of a soluble lyophilic material, such as amphipathic surfactants, leads to 
repulsion of the particles.117 The lyophilic materials usually contain two components, one 
that adsorbs to the surface of the metal, while the other is soluble in the dispersion 
medium. In order to describe the total potential energy (VT) of interaction is calculated: 
VT = VR + VA + VS 
in which VR is the repulsion potential energy, VA is the attraction potential and VS is a 
structural term. The Van der Waals attractions between particles is relatively small 
(Figure 2.4) where the potential barrier for the dispersion is minimal. The less important  
 
 
Figure 2.4 – Potential diagram for sterically stabilized particles (VT = VR + VA + VS)114 
 
contribution of the Van der Waals attraction in inducing aggregation of sterically 
stabilized dispersions is in sharp contrast with its role in causing coagulation in 
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electrostatically stabilized dispersions. The steric stabilization thus depends on the 
adsorbed ligands and when two of the protected particles approach one another, 
thermodynamically the ligating material experiences a loss of entropy and a gain in free 
energy. This results in a repulsion of the particles.118 This protects colloids from 
aggregation by electrolytes in both aqueous and non-aqueous media. 
 
2.5 – Optical properties of metal nanoparticles 
 
As the synthesis of GNPs developed in the 20th century, physicists began working on 
calculations to explain the optical properties of colloidal gold. Mie founded an incredible 
breakthrough in this area.119 Motivated to explain the color, he calculated the theoretical 
absorption and scattering patterns given off by metal particles. His paper included the 
calculation of absorption spectrum for gold sols in water, as well as absorption and 
scattering spectra as a function of particle size for spherical gold particles.  
 
Metal colloids, such as silver and gold, with r « λ respond to incident electromagnetic 
waves as seen in Figure 2.5. This scheme depicts the influence of the external field on the 
electrons on the surface of the particles. The electrons are displaced from the positive 
charges in the metal and thus provide Mie resonances or surface plasmon resonances.120 
This term comes from the effect producing the restoring force being the surface 
polarization. 
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Figure 2.5 – Interaction of spherical particles with external electromagnetic field 
 
The colloid’s color can be described using the dielectric function, ε(ω). In colloids with a 
diameter larger than 10 nm, the function has a value of the bulk metal. When the colloids 
have diameters smaller than 10 nm, the dielectric functions vary as a function of particle 
size. 
 
The Lorentz-Drude-Sommerfeld Model helps to explain the optical properties by treating 
the ions and electrons as simple harmonic oscillators.121 Using this model, the 
understanding of collective oscillations of free electrons is elucidated. In this theory, the 
electrons are assigned an me and a velocity v giving an electric field of 
 
E = E0 exp (-iωt)     2.3 
 
At frequency ω, the electron in the metal is accelerated and collides with the lattice, other 
electrons and impurities present in the material at a rate proportional to v. When 
collisions occur, v is reduced to 0 and the average velocity of a single electron can be 
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calculated to eEτ/me where τ is the time between collisions. If we apply this to a 
collection of electrons, the polarization P in an isotropic media connects the dielectric 
function defined by 
P = χε0E = ε0(ε-1)E      2.4 
 
where χ is the electric susceptibility. If we further express the dielectric function in terms 
of the electric susceptibility, we get  
    2.5 
where  and is the dielectric function for free electrons per unit 
volume and  is the Drude plasma frequency in terms of N 
(concentration of free electrons in metal).122 The dielectric function can then be defined 
as  
     2.6 
This is the Drude model for optical properties for a free-electron metal and can be used to 
describe the concentration of electrons on the surface as seen in Figure 2.5. 
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Figure 2.6 – The real and imaginary parts of ε(ω) of a Drude model as a function of frequency (ω) in eV. 
ωp = 10 eV and ωd = 1 eV.114 
 
Figure 2.6 shows that when the applied field shifts the oscillating electrons out of phase, 
ε1(ω) is negative over a wide range. Also, ε1(ω) is negative in the frequency below the 
the bulk plasma frequency (ωp) of the metal due to the polarization field being larger and 
opposite in sign to the applied field. 
 
This model explains the optical response to a collection of free electrons without a 
restoring force. Since metal nuceii are shielded by neighboring conduction electrons, a 
restoring force is not available except when a small dipole is created by an incident light 
wave. This sets up a surface polarization allowing the free electrons to have a restoring 
force and oscillate. Since the displacement of electrons is not in phase with the applied 
field, the displacement can be written as  with amplitude A and phase angle 
φ.122 These are defined as 
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     2.7 
The amplitude can be plotted as a function of frequency (in eV) as seen in Figure 2.7 
 
 
Figure 2.7 – Plot of A of a one-oscillator (Lorentz) model. ω0 = 6 eV and ωd = 1 eV.105 
 
The maximum is seen where ω  ω0 and its height full-width-half-max is inversely 
proportional to ωd.  
 
When solving for a multi-electron system, the harmonic oscillator equation is expanded 
to 
   2.8 
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in which N is the free electron concentration. The real and imaginary dielectric function 
are then respectively extrapolated as 
    2.9 
 
This leads to the Lorenz model for a concentration of electrons in a metal having a 
restoring force. The optical amplitude can be plotted versus amplitude to reveal 
 
Figure 2.8 - Plot of A of a Lorentz model with the real and imaginary parts of the dielectric function of a 
harmonic oscillator. ωp = 10 eV , ω0 = 6 eV and ωd = 1 eV105 
 
In Figure 2.8, it is seen that ε1(ω) is negative at ω0. The figure helps explain of the effect 
of absorption of the surface plasmon resonances for metal nanoparticles as compared the 
the bulk metal. 
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2.6 – Nanoparticle Absorption of Light 
 
Loss of intensity of an incident light when interacting with nanoparticles is related to the 
nanoparticle’s absorption and scattering cross sections. The intensity loss by absorption 
and elastic scattering result in a total extinction cross section 
     2.10 
The Beer-Lambert law can be used to calculate the intensity of transmitted incident light, 
I(x) in relation to the extinction cross section using the formula 
     2.11 
where I0 is the intensity of the attenuation of a parallel beam of incident light and x is the 
path length in cm. This can be related to absorbance, A, by taking the log123 
    2.12 
Mie theory can be used to expand the fields into partial waves of different spherical 
symmetries.120 The dielectric function εm, the extinction cross section of a medium, with 
embedded nanoparticles is used in the expansion. The Mie formula can be simplified to 
   2.13 
with V0 = 4/3πr3 the particle volume and ε(ω) the dielectric function of the particle. The 
real part of the dielectric function is defined as 
     2.14 
with ε∞ the high frequency dielectric constant. We can then use this to plot an absorption 
model of spherical nanoparticles (Figure 2.9). The damping parameter ωd is related to the 
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mean free path of the conduction electrons, Rbulk and and the velocity of the electrons at 
the Fermi energy vf124 
      2.15 
So as particle size decreases, the damping parameter increases causing the band to 
broaden and the intensity to decrease. 
 
Figure 2.9 – Calculated absorption band for surface plasmon resonance of silver colloids. Mie dipole 
approximations show the effect of the damping parameter ωd. As the ωd increases, the intensity drops. The 
damping frequencies in eV are 0.4 (black), 1.4 (red), 2.4 (green) and 3.0 (blue).124 
 
2.7 – Effect of nanoparticle size on plasmon band 
 
There is no size dependence in the dipole approximation (Equation 2.13) except for the 
intensity change from nanoparticle’s volume V0 with radius r. The position of the 
plasmon absorption max (λmax) has been seen to have a red or blue shift depending on 
size.120,125 El Sayed’s group studied the size of colloidal GNPs between 9 and 99 nm and 
found that the plasmon band red-shifts with increasing diameter as seen in Figure 2.10. 
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The figure shows absorptions from silver nanoparticles ranging from 10 nm to 100 nm 
revealing a red-shift with increasing size. 
 
Mie theory does not account for size dependence and the dielectric function must be 
altered to account for the diameter of the nanoparticles [ . This size 
dependence is only seen for nanoparticles with a diameter smaller than the mean free path 
of the conduction electrons.126 This results in a size-dependent absorption cross section in 
the dipole approximation, or commonly known as an intrinsic size effect.120 The average 
electron collision time, τ (relaxation time), is the average of the τI which is an effect from 
collisions with phonons, lattice defects and impurities.125,126 
 
Figure 2.10 – Absorption spectra of spherical gold nanoparticles of varying sizes. The spectra are 
normalized at their plasmon absorption maxima. The corresponding shifts are 517 nm for a 9 nm particle, 
521 nm for a 22 nm particle, 533 nm for a 48 nm particle and 575 nm for a 99 nm particle.125 
 
The damping constant γ is related to the collision time by 
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    2.16 
The surface of small particles acts as another collision process due to the comparable size 
of the particles to the mean free path of electrons, which in very small particles reduces 
the effective mean free path. This is dominated by the collision of conduction electrons 
with the particle’s surface, therefore the particle radius r requires the damping constant to 
be calculated as125,126 
     2.17 
where γ0 is the bulk damping constant seen in equation 2.16, vf is the velocity of the 
conduction electrons at the Fermi energy and A is the specific scattering processes.125 
 
For larger nanoparticles (r > 15 nm), the extinction cross section depends on higher-order 
multipole modes within the Mie equation. The extinction spectrum is consequently 
dominated by dipole absorption as well as quadrupole and octopole absorption and 
scattering processes.125 The superposition of the multipole oscillations peaking at 
different energies contributes to the total plasmon band absorption. Retardation effects 
lead to the broadening of the plasmon band though the increase in FWHM can also be 
caused by the interaction the dipole and the higher-order oscillatory motions of the 
electrons.125  
This leads to an extrinsic size effect, which affects the plasmon resonance when the 
complex dielectric function of the bulk material is used in the Mie equation and size is no 
longer a factor. 
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2.8 – Ansiotropic Nanoparticles and their Light Absorption 
 
Mie’s theory is only applicable to spherical particles. When Mie compared his theoretical 
plots to that of the experimental results of his research, Mie observed a deviation in the 
spectra in certain cases.119 Mie believed the behavior was from ellipsoidal particles. This 
has been explained for rod-shaped nanoparticles, also known as nanorods. For nanorods, 
the orientation of the particle axis dictates the plasmon oscillation of electrons with 
respect to the oscillating electric field of incident light. The result is two absorption 
bands, one being for the transverse resonance and the other for the longitudinal 
resonance.127 Figure 2.11 shows the electron cloud modes interacting with incident light 
in both modes.  
 
a.  
b.  
Figure 2.11 – Schematic of two oscillating modes of nanorods. These modes give a transverse oscillation 
(figure a) and a longitudinal oscillation. 
 
The properties of the metal nanorods can be explained using Gans theory. Gans extended 
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the Mie theory to consider spheroid particles.128 He found that smaller aspherical 
particles allowed for plasmon bands at longer wavelengths than spherical particles of 
comparable size. It should be noted that in sub-nm sized particles, quantum mechanical 
methods don’t allow for continuous density of states. Therefore, very small metal 
nanoclusters do not display the plasmon resonances seen for larger free-electron metal 
nanoparticles.129  According to Gans theory, the extinction coefficient (κ) for N 
nanoparticles with volume V0 can be expressed in the dipole approximation as130,131 
   2.18 
in which Pj are the depolarization factors used to calculate absorption of nanorods for the 
three axes A, B, and C seen in Figure 2.11. The geometrical factors Pj for the nanorods 
along the respective axes are 
 
    2.19 
     2.20 
with 
    2.21 
where R is the aspect ratio defined by L/d.130,131 El-Sayed’s group calculated the 
absorption spectra of gold nanorods using equation 2.18 for a series of aspect ratios with 
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measured dielectric functions. This is illustrated in Figure 2.12 where El-Sayed’s group 
modeled several sizes of nanorods with aspect ratios from 2.6 to 3.6. Using a medium 
dielectric constant of 4, it was shown that longitudinal plasmon band red-shifts 150 nm as 
the aspect ratio increases. It is also shown that the red-shift in absorption maxima of the 
longitudinal band follows a linear trend. 
 
 
 
 
Figure 2.12 – Absorpton calculations of nanorods with increasing aspect ratio and increasing dielectric 
constants respectively. Both show linear shifts in absorption maxima for the longitudinal plasmon band 
(inserts).130 
 
An equation was then extracted to approximate the lmax with aspect ratio R and dielectric 
constant em as130 
    2.22 
We can see that both the aspect ratio and the dielectric constant give a linear response to 
the incident light. For example, in Figure 2.12, a graph of the λmax versus various 
dielectric constants at a constant aspect ratio of 3.3 reveals a linear regression. 
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Synthesis of Gold Nanoparticles in Soy Lecithin 
3.1 – CTAB standard versus Soy Lecithin 
 
Introduction 
As previously discussed, the electronic and optical properties of nanoparticles are 
determined by both their size and shape.97-109 Chemically influencing the shape of GNPs 
has been studied by many methods.  A seeded method using cetyltrimethylammonium 
bromide (CTAB) is the most popular method for synthesizing anisotropic GNPs.52,130-
138,146 Small gold seed particles between 4 and 5 nm are synthesized using a strong 
reductant. These seeds allow for a nucleation site for larger gold nanoparticles to grow. 
CTAB can then be used as a directing agent, allowing for growth in one or two 
dimensions depending on the growth environment.44,56,59,62,132 Its seen that when using 
CTAB with HAuCl4 as a growth solution, rod shaped nanoparticles could be synthesized 
with great efficiency.132 However, if the growth solution is altered by removing seed and 
a competing halide salt is added, such as KI, prismatic nanoparticles are produced. A 
difference in seed morphology also produced different shapes of GNPs. Sionnest’s group 
showed that multiply twinned seeds added to a growth solution in the presence of AgNO3 
(catalyst) gave a bipyramidal shaped GNP while Pérez-Juste et. al. found that using 
multiply-twinned seeds with no catalyst produced nanorods containing penta-twinned 
facets running the length of the nanorods.133  
 
Although CTAB is versatile as a shaping agent in GNP growth, the biocompatibility of 
GNPs grown in CTAB have not shown great promise.134 Many methods of manipulation 
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have been employed to correct this. One popular method is ligand exchange using natural 
extract.65,135 Soybeans have been used as a stabilizing agent against nanoparticle 
aggregation in many instances.136,137,138,139  
 
Soy lecithin has been of considerable interest due to the presence of phospholipids, the 
main building block of cell membranes.140-145 One of the more popular components 
present in soybean lecithin for ligand exchange is phosphatidylcholine (PC).  PC consists 
of a phosphocholine head-group attached to a glycerol linker. Each of the two remaining 
oxy groups on the glycerol contains fatty acids. These fatty acids are composed of a long 
carbon chain, which are either saturated or contain any number of double bonds (Figure 
3.1). However, PC is not the only phosolipid component present in soybeans. Many other 
components are present such as phosphatidylethanolamine (PE), lyso-phospholipids in 
which one of the fatty acid tails are missing, and phosphatidic acid (PA), which lacks a 
carbonyl chain off the phosphate head group.  
 
PC has often been used for multiple reasons.146-152 Its similar structure to CTAB makes it 
a possible shape-directing agent. Its makeup in nature gives it viability for 
biocompatibility. And its ability to organize into micelles makes it ideal for prevention of 
aggregation of GNPs. The lamellar nature of lecithin in aqueous media allows for 
possible growth of nanomaterials in the aqueous cavities of the resulting liposomes. 
Micelles form when the hydrophobic ends of the phospholipids flock together in the 
interior of the sphere while the polar head-groups are exposed to the water. These 
nanoreactors can restrict the size of the particle according to the size of the interior of the 
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micelle. These droplets are randomly displaced and subjected to Brownian motion, 
exchanging their water content and reforming into two different micelles.139 This allows 
for reformation of the micelles giving rise to different products in the nano-scale. This 
makes the micelles ideal for materials synthesis. 
 
It has been shown that the bromide ion in CTAB performs an ionic exchange with 
chloride ions in the gold compounds. Thus an alternate crystal facet is formed when 
stacking of the gold atoms occurs.150 This in turn causes stacking in a pentafold twinned 
crystal facet along the [110] direction. The sections are separated by (111) planes 
containing {100} side facets as seen in HRTEM.151 This anion exchange can be tracked 
using UV-Vis spectroscopy.116 
 
Using soy lecithin, we set out to mimic the CTAB synthesis and make gold nanorods. 
What we found was that the plethora of components cause different reactions to take 
place and, although PC is a common ligand exchange agent, PC is not ideal for the 
synthesis of gold nanorods. We found that PA was a better reagent for anisotropic 
growth, and though it produces prismatic shapes, the resulting optical properties followed 
those of gold nanorods. 
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3.2 – Experimental 
 
L-α-Phosphatidylcholine Type IV-S ≥ 30% TLC (PC30), cetyltrimethylammonium 
bromide (CTAB), potassium cyanide and Agarose Type II Medium EEO, and L-ascorbic 
acid were purchased from Aldrich. Hydrogen tetrachloroaurate (III) hydrate and 
hydrogen tetrabromoaurate (III) hydrate were purchased from Strem Chemicals Inc. 
Potassium bromide was purchased from Acros. Sodium borohydride (98%) was 
purchased from J.T. Baker.  L-α-Phosphatidylcholine (Soy-95%) and L-α-Phosphatidic 
Acid (Egg, Chicken-Monosodium Salt) were purchased from Avanti Polar Lipids. 
Centrifugation was performed on a Sorvall RC-6 equipped with a SS-34 rotor. Samples 
were run at 3000 rpm (1068 x g) for 20 minutes. Milli-Q H2O was used at 18.1 mΩ 
resistance. 
 
Preparation of HAuBr4 with CTAB 
A 10 mM solution of HAuCl4 was prepared by dissolving solid HAuCl4 (450 mg, 0.132 
mmol) in milliQ water (13.2 mL). Diluted solutions were further prepared using milliQ 
water (1.25 mM, 0.625 mM, 0.313 mM and 0.156 mM). A 100 mM solution of 
cetyltrimethylammonium bromide was prepared by adding CTAB (716.0 mg, 1.96 mmol) 
to milliQ water (19.6 mL). This was added to the gold solutions containing 0.313 mM 
and 0.156 mM HAuCl4 and UV-Vis spectra were taken both with and without added 
CTAB (1.0 M). 
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Preparation of HAuBr4 with KBr 
A solution of potassium bromide was prepared by adding KBr (119.0 mg, 2.02 mmol) to 
milliQ water (1.2 mL). HAuCl4 solution (10 mM) was diluted to 0.313 mM. Several 
solutions were prepared and to each sample of HAuCl4 was added KBraq in varying 
amounts [0.5x (Br- to Cl-) - 6.0x]. UV-Vis spectra were taken of each solution. All 
dilutions were made using milliQ water. 
 
Preparation of CTAB gold seed 
CTAB seed was prepared fresh prior to each experiment.  Briefly, CTAB (100 mM, 5 
mL) was stirred vigorously at 30°C and HAuCl4 . xH2O (10 mM, 125 µL) was added 
followed by immediate addition of NaBH4aq (10 mM, 300 µL).  The resulting brown seed 
solution was allowed to react 45 min to one hour prior to use. 
 
Preparation of CTAB growth solution 
To CTAB solution (10 mL, 100 mM) at 30°C was added HAuCl4 (250 µL, 10 mM), 
AgNO3 (400 µL, 10 mM) and HCl (100 µL, 1 M).  While stirring vigorously, ascorbic 
acid (80 µL, 100 mM) was added and when color disappeared completely, CTAB seed 
(25 µL) was added and allowed to react 18 h prior to analysis. 
 
Preparation of PC30 liposomes 
PC30 stock solution was prepared by dissolving PC30 (200 mg, 0.080 mmol) in minimal 
cyclohexane, which was immediately dried by rotary evaporation to give a thin film. H2O 
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(20 mL) was then added to the vial which was shaken 30 seconds.  The cloudy solution 
was then sonicated for 15-20 min, upon which the solution became translucent. 
 
Preparation of PA stock solution 
A vial was charged with PA (15 mg) and hydrated with milliQ H2O (4.5 mL). The vial 
was shaken for 5 minutes. 
 
Preparation of PC95 stock solution 
For initial GNP growth, PC95 stock solution was prepared by dissolving PC95 (200 mg, 
0.245 mmol) in minimal cyclohexane, which was immediately dried by rotary 
evaporation to give a thin film. H2O (20 mL) was then added to the vial which was 
shaken 30 seconds.  The cloudy solution was then sonicated for 15-20 min. 
For PC95 solutions used with PA, vials were charged with varying masses of PC95 (i.e. - 2 
x 6 mg, 12 mg, 18 mg, 24 mg and 2 x 30 mg respectively) and the PC dissolved in 
minimal cyclohexane. These were then rotary-evaporated to give thin films and 
rehydrated with milliQ H2O (2 mL each). PA (500 µL) was charged into 5 vials of PC95 
(1 x 6 mg, 12 mg, 18 mg, 24 mg and 1 x 30 mg respectively). The resulting solutions 
were sonicated in a bath sonicator for 15 minutes and all diluted with milliQ H2O (to 17.5 
mL each). 
 
Preparation of chloride derived gold seed using PC 
Gold chloride seed solution was prepared fresh before prior to each experiment. Briefly, 
to PC stock (1 mL) diluted to 5 mL with milliQ H2O was added HAuCl4 . xH2O (10 mM, 
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125 mL), KBr (1.65 M, 7.5 mL) and while stirring vigorously, NaBH4aq (10 mM, 600 
mL) was quickly added.  The resulting purple seed solution was allowed to react 45 min 
to one hour prior to use. 
 
Preparation of bromide derived gold seed using PC 
Gold bromide seed solution was also synthesized fresh prior to each experiment.  Briefly, 
PC stock (1 mL) was diluted to 5 mL with milliQ H2O in a vial and while vigorously 
stirring, aqueous HAuBr4 . xH2O (10 mM, 125 µL) was added followed by immediate 
addition of NaBH4aq (10 mM, 300 µL). The resulting purple seed solution was allowed to 
react 5 min prior to use. 
 
Preparation of growth solutions with KBr 
A typical chloride growth solution was prepared by diluting PC stock (2 mL) with H2O 
(15 mL). To this was added aqueous HAuCl4 . xH2O (10 mM, 400 µL), KBr(aq) (1.65M, 
24.3 µL) and chloride derived lecithin gold seed (40 µL). The resulting orange solution 
was vigorously stirred and ascorbic acid (100 mM, 40 µL) was immediately and rapidly 
added. The solution immediately became transparent and then began to darken to a darker 
red/purple within 5 min.  The resulting solution was allowed to react 18 h prior to 
analysis. 
 
Preparation of growth solutions with HAuBr4 
A typical bromide growth solution was prepared by diluting PC stock (2 mL) with H2O 
(15 mL). To this was added aqueous HAuBr4 . xH2O (10 mM, 400 µL), bromide derived 
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lecithin gold seed (40 µL). The resulting orange solution was vigorously stirred and a 
rapid addition of ascorbic acid (100 mM, 40 µL) was immediately performed. The 
solution immediately became transparent and then began to darken to a darker red/purple 
within 5 min.  The resulting solution was allowed to react 18 h prior to analysis. 
 
Centrifugation 
Centrifugation was performed on a Sorvall RC-6 equipped with a SS-34 rotor. Samples 
were run at 3000 rpm (1068 x g) for 20 minutes and pellets collected and diluted to 1 mL. 
 
Preparation of gel electrophoresis rig 
Agarose (500 mg) was added to Tris – Boric Acid – EDTA (TBE) buffer (0.5 X, pH 8.4, 
100 mL) and heated until agarose was uniformly dissolved. This was immediately poured 
into the chilled gel form and allowed to cool at 4ºC for 8-15 hours. The gel form is then 
transferred to the rig containing a Spectra/Por®RC Membrane (MWCO: 2-8,000). The 
rig was charged with TBE (0.5 X) buffer and the flow column connected to a paristaltic 
pump running at ~200 mL/hr. Lipid-coated GNPs were centrifuged to remove excess 
unbound lipids and concentrated down to a volume of 1 mL. These solutions were mixed 
with glycerol (20 µL) and loaded onto the gel. Gels were run at 300 V and fractions 
collected and analyzed by UV-Vis. 
 
Preparation of KCN and sample dissolution 
KCN was prepared freshly and used within 24 hours of preparation. KCN (200 mg) was 
dissolved in mQ H2O (10 mL) to make a 307 mM solution. KCN (50 µL) was added to 
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each fraction of GNP solution off the gel and allowed to react 18 hours. Fractions were 
then frozen at -80 ˚C for 4 hours and lyophilized for 24 hours. A small amount of 
cyclohexane was introduced into each fraction to extract organic material from the salt 
and filtered and allowed to dry. MeOH (1 mL) was then used to dissolve the extract and 
MS analysis performed. 
 
Instruments Absorbance	  spectra	  are	  obtained	  on	  an	  Agilent	  8453	  UV-­‐visible	  Spectrophotometer	  with	   a	   diode	   array	   using	   a	   1.0	   cm	  path	   length	   quartz	   cell.	   	   Transmission	   electron	  microscopy	  (TEM)	  images	  are	  acquired	  on	  a	  Tecnai	  F-­‐20	  FEI	  microscope.	  Images	  are	  collected	   at	   an	   acceleration	   voltage	   of	   200	   kV	  using	   a	   CCD	  detector.	   	   Samples	   are	  prepared	  by	  drop	  casting	  (5	  µL)	  solutions	  of	  nanoparticles	  onto	  carbon-­‐coated	  (300	  Å)	  Formvar	  films	  on	  copper.	  Samples	  are	  dried	  for	  at	  least	  1	  h	  before	  images	  were	  obtained.	   For	   more	   dilute	   samples,	   multiple	   castings	   are	   performed	   on	   the	   same	  grid.	   	   Nanoparticle	   size	   analysis	   and	   length	   to	   width	   aspect	   ratio	   are	   performed	  using	  ImageJ	  software	  after	  applying	  a	  band	  pass	  filter	  to	  the	  images	  and	  adjusting	  the	   threshold.	   Mass Spectrometry samples were analyzed on a LTQ-Orbitrap mass 
spectrometer. The flow rate was set at 0.20 mL/min. Mobile phases consisted of 95:5 
MeOH:H2O and remained constant for each run. The injection volume was 20 µL. The 
mass spectrometer was operated under positive electrospray ionization with a voltage 
4000 V in positive mode, the heater was set at 300 ˚C, the curtain gas (N2) was kept 
constant at 50 psi. Quantitative analysis was monitored by total ion count and ESI results 
were analyzed on Xcalibur analysis software. 
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3.3 – Results and Discussion 
HAuCl4 versus HAuBr4 in synthesis 
PC contains a trimethylammonium headgroup similar to that of CTAB and long fatty-
acid tail groups (Figure 3.1). 
 
 
Figure 3.1 – Schematic of PC and CTAB. PC is depicted above with two tail groups off a glycerol linker 
while the PC makes up the head group. Note the similar headgroup to CTAB (bottom) 
 
Using PC as our capping ligand, we started the synthesis using a yellow HAuCl4 solution 
and reducing with ascorbic acid. This resulted in a blue solution of nanoparticles which 
immediately began aggregating out of solution. UV-Vis and TEM were taken, and as 
seen in Figure 3.2, only one plasmon band was seen in the UV-Vis spectrum. TEM 
(Figure 3.2) showed only spheres resulting from this particular synthetic technique. 
 
 
	   46	  
 
Figure 3.2 – UV-Vis spectrum and corresponding TEM of GNPs synthesized using HAuCl4 in soybean 
extract. Red trace was taken with GNPs synthesized using HAuCl4 in the growth solution and the blue trace 
using HAuBr4 
 
The use of HAuCl4 gave only one plasmon band at 532 nm. The corresponding TEM had 
a scattering of anisotropic shapes, but an estimated 98% of the particles were spherical. 
This accounts for single plasmon band in the UV-Vis absorption spectrum. As we desired 
anisotropic shapes for our nanoparticles, we deduced that the Br- was key in the shape 
control of nanoparticles. As CTAB is added to a solution of HAuCl4, the solution turns a 
bright orange. 
 
We found in previous studies that the shift in λmax is due to bromide exchange.116 It has 
been shown that the UV-Vis spectrum for the addition of CTAB to HAuCl4 red-shifts as 
the bromide exchange takes place. This can be seen in Figure 3.1 in which we see the 
λmax shifts from 295 nm to 390 nm. This indicates that anion exchange is indeed taking 
place. To support this, we added KBr to HAuCl4 solutions and UV-Vis spectra taken of 
each addition (Figure 3.2). 
- HAuCl4 
- HAuBr4  
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Figure 3.3 – UV-Vis spectra showing addition of CTAB to HAuCl4 
 
It can be seen that as the molar ratio of Br- to Cl- increases, the shift follows the same 
trend as that of CTAB addition. The λmax red-shifts from 295 nm to 385 nm. We see that 
by 4x the molar ratio of KBr to HAuCl4, that the λmax has shifted to its maximum shift 
indicating a propensity of the bromide to coordinate to the gold(III) center. 
 
 
Figure 3.4 – UV-Vis spectra showing addition of KBr to HAuCl4. Note all amounts are expressed in molar 
ratios of KBr to HAuCl4 and all spectra are normalized (Find extinction for aucl and aubr) 
 
Using HAuBr4, we repeated the synthesis. The orange solution of HAuBr4 was added to a 
lecithin solution and ascorbic acid used to reduce the gold. A red solution resulted and 
- 0.313 mM HAuCl4 
- 0.313 mM HAuCl4 + CTAB 
- 0.156 mM HAuCl4 
- 0.156 mM HAuCl4 + CTAB  
Added	  KBr	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UV-Vis and TEM were taken of the GNPs. Again, we see in Figure 3.5, only one 
plasmon band results at 532 nm from spherical nanoparticles, as seen in the adjoining 
TEM. Also, we see that the width of the plasmon band when performing a synthesis with 
HAuCl4 is broader than that when using HAuBr4. This leads to the color difference 
between the two solutions: Synthesis with HAuCl4 being blue in color whereas a 
synthesis with HAuBr4 is red. 
 
 
 
Figure 3.5 – UV-Vis spectrum and corresponding TEM of GNPs synthesized using HAuBr4 in soybean 
extract 
 
This, however, does not lead to anisotropic growth. It has been shown that seed mediated 
synthesis is needed for anisotropic growth.52 In a typical growth, a seed solution is 
prepared using a strong reductant such as NaBH4. The seeds are shown to give a 
nucleation point and the surfactant directs the one-dimensional growth.57 It is believed 
the surfactant blocks growth on the {110} facet of the gold crystal giving growth in a 
one-dimensional direction.137 This produces a majority of uniformly sized gold nanorods 
(Figure 3.7). 
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Figure 3.6 – UV-Vis of nanorods using CTAB as the capping agent. The nanorods have an average aspect 
ratio of 7. Note the ratio of the red-shifted plasmon to the blue-shifted plasmon. 
 
Therefore we modified our synthesis incorporating a seed mediated method into our 
synthesis. Seeds were prepared using lecithin and HAuBr4 and reduced using NaBH4. 
Seeds were then introduced into our growth solutions and monitored by UV-Vis. Figure 
3.7 shows a UV-Vis spectrum of the resulting growth solution. Along with the 
characteristic blue-shifted plasmon band at 532 nm, a second plasmon band is seen at 775 
nm. This plasmon band is a result of anisotropic growth. This is one aspect that makes 
anisotropic growth desirable. Using UV-Vis spectroscopy, the reaction can easily be 
monitored. As growth of the longitudinal axis increases, the NIR plasmon band increases 
in intensity and red-shifts. As seen in a growth of CTAB (Figure 3.6), the intensity of the 
red-shifted plasmon band is much more intense than that of the blue-shifted plasmon 
band. 
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Figure 3.7 – UV-Vis spectrum of gold nanoparticles grown with HAuBr4 and PC capping agent. 
 
The growth of the nanoparticles in one dimension or two dimensions gives rise to the red-
shifted plasmon band. The cross section of the nanoparticles is what is believed to give 
the blue-shifted plasmon band. Since rod-shaped GNPs have such a small cross sectional 
area, the oscillation of the electrons in the transverse band is stunted and therefore, a 
small absorption band is seen in the blue. Since our spectrum shows a larger blue-shifted 
absorption band, one of two (or both) scenarios are possible. We have a mixture of 
anisotropic nanoparticles, or we have different shapes than the rod-like nanoparticles. To 
confirm this, TEM was taken of the nanoparticles formed in the PC capped growth 
solution. As seen in Figure 3.8, a multitude of shapes are present on the TEM grid. A 
majority of the nanoparticles are spherical in shape, however, prismatic nanoplates, 
hexagonal nanoplates and rods are also dispersed throughout the sample. 
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Figure 3.8 – TEM image of crude nanoparticle synthesis using HAuBr4 and PC as a capping agent. Note 
the plethora of shapes and sizes. 
 
This synthesis was also compared to a seed mediated synthesis in which HAuCl4 and KBr 
were substituted in for HAuBr4. As more KBr was added to the growth solution, you see 
a rise in intensity of the NIR plasmon band (Figure 3.10). There is also a shift of the 
plasmon band towards the red as the concentration of KBr increases from 4x the molar 
concentration of HAuCl4 to 12x. 
 
 
Figure 3.9 – UV-Vis spectra of KBr being added to seed mediated growth solution of PC and HAuCl4. 
 
This is further evidence that the bromide ion is needed for the growth of anisotropic 
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nanoparticles. As bromide is introduced to the growth solutions, the NIR (red-shifted) 
plasmon band appears and grows. However, as discussed later, the shapes found in the 
solution were not rod shaped GNPs as was initially believed. 
 
Capping agent 
CTAB is the standard capping agent for use in gold nanorod growth. However, it is not 
biocompatible. GNPs synthesized with CTAB therefore must be post-processed by 
coating the particles with polymers or ligand exchange performed to make the GNP more 
biocompatible.152,153,154 Soybean PC is from a natural product and forms liposomes in 
aqueous media. These have a much higher propensity for compatibility in medicinal 
applications. 
 
Thus far, we have discussed synthesis using a 30% PC (PC30) extracted from soybeans. 
The idea that PC is a compatible substitute for CTAB from the similar structure of the 
ligands has been utilized for surface modification of GNPs.65 We want to attempt shape 
controlled synthesis of GNPs from a biocompatible template. However, when we altered 
the synthesis to use a more pure form of soybean PC, we found some interesting results. 
 
Using PC30 as the template allowed for a plethora of sizes and shapes of nanoparticles in 
the growth solution. In an attempt to narrow the shape distribution, a solution of 95% PC 
(PC95) was substituted for PC30 in the synthesis. The resulting nanoparticles were 
analyzed by UV-Vis and TEM and compared to the corresponding nanoparticles 
synthesized from PC30 (Figure 3.11). 
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a) 
 
b) 
 
Figure 3.10 – UV-Vis and corresponding TEM of a) PC95 synthesis and b) PC30 synthesis respectively 
 
As can be seen in Figure 3.11, a PC95-GNP gives agglomerates of nanoparticles. The low 
intensity and scattering is evidence of aggregate formation in nanoparticles solutions and 
the TEM confirms that agglomerates of nanoparticles formed upon synthesis. This was 
also seen by the naked eye in the storage vial. Within 24 hours, a thin black precipitate 
could be seen in the bottom of the vial.  
 
The single plasmon band absorption indicates that predominately only spherical particles 
form using PC95. The breadth of the band is also broader than that of nanoparticles 
synthesized with PC30. This is seen in the color of the growth solution as was also seen 
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when using HAuCl4 in the synthesis above. The color of the solution was purple instead 
of red (Figure 3.11). 
 
 
Figure 3.11 – Picture of vials containing PC30 growth (left) and PC95 growth (right). Note 
the precipitate in the PC95 sample 
 
Due to this result, it is not believed that the PC is the component allowing for shape 
control. This will be discussed in a later section. However, this did lead to an added 
advantage in our synthetic technique. 
 
Both PC95 and CTAB synthesized GNPs fell out of solution within an hour after 
synthesis. Using the soybean extract PC30 in the synthesis, however, increased the 
lifetime of the nanoparticles in solution up to six months when stored at 4˚C. Long shelf-
lives of GNPs is very important when applying the nanoparticles to a medicinal use. 
 
When using an impure natural product such as PC30 as a capping ligand for nanoparticles, 
it becomes more difficult to discern what materials are on the surface of the nanoparticle 
as compared to a synthesis using a pure compound (i.e. CTAB). This becomes especially 
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important when you consider shape control. One and two-dimensional growth of 
nanoparticles are usually driven by a number of particular components which block 
growth on specific crystal facets. CTAB, for example, blocks growth on the {110} facet 
allowing for one-dimensional growth of GNPs into rod-shaped nanoparticles.52 Bromide 
was found to be required for directed growth, however contaminants such as iodide have 
been found to stunt growth of rod-shaped GNPs.61 
 
PC30 contains a plethora of compounds that may have a role in the synthesis of 
anisotropic GNPs, particularly the nanoprisms seen above. Though the main components 
of PC30 are PC and phosphatidylethanolamine (PE), there are also small amounts of 
sterols, tocopherols and other plant byproducts, including dissociated fatty acids other 
phospholipids. Isolating the capping ligands is difficult  
 
when solutions of GNPs contain all these compounds and separation is needed to seclude 
the specific ligands for identification. Traditionally, nanoparticles are separated using 
centrifugation at varying speeds to separate sizes, however shape separation is more 
difficult. 
 
Our first thought was to identify the components in PC30 using HPLC-MS. We can then 
re-spike these components into growth solutions and test for plasmon absorption 
enhancement. We found that PC30 contained mostly lyso-PC and diacyl-PC components 
(Table 3.1). We then respiked many of these components into our growth solutions and 
monitored the growth by UV-Visible spectroscopy. However in every re-spike 
	   56	  
experiment, we found that the component added degraded any anisotropic growth (Figure 
3.12). Other components known to be in PC30, which didn’t show up on LC-MS such as 
cholesterol and sodium linoleate, were also spiked into growth solutions and also lead to 
degraded NIR plasmon band growth. Since this method was not proving fruitful, a more 
efficient approach to identifying the responsible ligand for anisotropy was employed 
using gel electrophoresis. 
 
Table 3.1 – List of mass identities found in PC30 
Identity Mass (m/z) Retention time (min) 
Lyso-EPC 578.4 2.2 
Lyso-PPC 496.3 2.5 
Triarachidicglyceride 947.3 3.5 
Di-LPC 782.6 5.8 
OLPC 784.6 7.4 
POPC 760.6 9.5 
SLPC 786.6 10.1 
GPPC 788.6 13.1 
 
 
 
Figure 3.12 – UV-Vis spectrum showing resulting GNP traces after  
several components are spiked into a growth solution. The black trace is 
a normal growth solution without any spike. 
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Figure 3.13 shows a slab gel of our nanoparticles run at 200 V. UV-Vis and TEM show 
that the nanoprisms move slower through the gel and therefore analysis of the later 
fractions are essential in determining the capping ligand leading to the gold nanoprisms. 
The nanoparticles were then studied using UV-Vis, TEM and MS. Gel electrophoresis 
has previously been utilized to separate shapes of nanoparticles.158,155 However, this 
wasn’t attempted on any samples containing unknown ligands to our knowledge.  
 
 
 
Figure 3.13 – Gel electrophoresis of anisotropic GNPs showing size and shape separation. Note the trailing 
of the bands as the plate-like nanoprisms are slower to move along the gel. 
 
Discovering that shape separation was possible, we utilized a gel prep column to collect 
fractions as they came off the gel and analyzed the fractions using TEM (Figure 3.14). It 
was also seen that the nanoprisms were single crystalline and equilateral in geometry 
(Figure 3.15). These factors are important in respect to the optical properties of the 
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GNPs.156 The resulting plasmon absorptions of each fraction were monitored by UV-Vis 
and an NIR plasmon absorption was seen growing as the fractions progressed (Figure 
3.15). We found that nanoprisms increase in population leading to an increase in the NIR 
plasmon band intensity in later fractions. Upon realizing this, we leached the GNPs from 
the capping ligand using KCN and extracted the organic ligands, using LTQ-OrbiTrap 
MS to analyze the makeup of these ligands. 
 
 
 
 
Figure 3.14 – A. Particles from front of gel band show only GNPs of a semi-uniform size B. Particles from 
tail of gel band show a multitude of nanoprisms, though there are still some smaller nanoparticles present 
 
 
Figure 3.15 – A. A UV-Vis analysis of several fractions from the column revealing a steady increase of the 
NIR absorption band (normalized at 532 nm). B. High resolution TEM showing uniform crystal lattice and 
SAED inset showing [111] zone axis with {220} diffraction spots. TEM also allows us to analyze the 
A B 
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geometry of a gold nanoprism and show that it is equilateral.  
 
Mass spectra show peaks corresponding to phosphatidic acid (PA) at 669.86 m/z (Figure 
3.16). This peak can be calculated as a PA ligand containing fatty acid tail groups of C 
16:0 and C 18:3. MS2 was attempted to confirm these tail groups, however the C 16:0 tail 
was the only peak to occur and was never consistent enough for positive identification. 
Though positive analysis of the exact ligand escaped us, we incorporated a sample of PA 
into our synthesis. 
 
  
Figure 3.16 – Mass spectrum of 3 concurrent fractions from a gel prep column showing a  
growth of the peak at 669.86 m/z. 
 
PA from egg yolk was spiked into PC30 and PC95 stock solutions prior to sonication in 
order for it to be incorporated into the liposomes. Although PC30 growth solutions 
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produced little difference in the NIR plasmon band when spiked with PA, PC95 showed a 
steady growth of an NIR plasmon band when PA was added to the system in 
consecutively larger amounts (Figure 3.17). In other words, as the ratio of PC95 to PA 
was decreased, a NIR plasmon band appeared and increased leading us to conclude that 
PA is essential in the growth of gold nanoprisms. As seen above, PC95 never produced 
nanoprisms or an NIR plasmon band. Another observation was the sharpening of the 
blue-shifted plasmon band. This indicates decreasing aggregation in the solution.  
 
 
 
Figure 3.17 – UV-Vis of varying ratios of PA to PC95. The higher the ratio of PA to PC95, the larger the 
intensity of the NIR plasmon band and the sharper the blue-shifted plasmon band. 
 
The source of the PA lipid is unknown. MS analysis of the original PC30 does not show 
any sign of PA, though many other phospholipid compounds are present. The appearance 
of PA could be due to a surface reaction occurring in the initial steps of the reaction, 
however, this is hypothetical and we have not found the source of the PA appearance. 
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3.4 – Conclusion 
We have shown that anisotropic nanoparticles can be synthesized using soybean extract 
and HAuBr4. The soybean extract has the advantage of being biocompatible as well as 
being cheap and readily available. It has also been demonstrated that bromide play a key 
role in the anisotropy of GNPs during synthesis. This can be seen when spiking samples 
of HAuCl4 with KBr. Substituting HAuBr4 for HAuCl4 enhances the synthesis giving 
more intense NIR-shifted plasmon bands. The resulting solutions are stable for months at 
a time and show promise for use in medicinal applications. However, this is not a result 
of the PC as we initially believed. Although, PC30 produces a relatively large population 
of prismatic GNPs, PC95 shows poor shape control as well as immediate aggregation out 
of solution. PA was identified as a critical component of the capping ligands on gold 
nanoprisms. Using gel electrophoresis, it was found that we could increase the 
nanoprisms population of our GNP solutions and mass spectrometry could be used to 
identify PA. Spiking PA into PC95 growth solutions revealed an NIR plasmon band 
indicative of anisotropic GNPs. As the ratio of PA to PC95 increased, so did the intensity 
of the red-shifted plasmon band. This is the first instance of the use of PA to grow 
anisotropic GNPs that we have seen. More experiments are being performed to discern 
the extent of the shape control of PA in seed mediated growth of gold nanoprisms.  
 
Shape-directing agents are of great importance in nanotechnology when considering GNP 
use in therapy. However, identifying a specific ligand responsible for shape-control in a 
conglomerate of components can be a challenge. Gel electrophoresis is mainly used in 
biology and biochemistry to separate biological molecules such as oligonucleotides and 
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protein strands.157 These molecules can be digested to break bonds and give the make-up 
of the strands in question. Other pre-processing may be required for proteins such as 
denaturing the molecule with sodium dodecyl sulfate (SDS) to apply a charge for 
carrying the molecule down the gel. When a current is applied to the gel, the molecules 
are carried down the gel according to size and charge and separated giving bands that can 
be applied to specific sequences allowing for qualitative analysis.157 
 
Using this data, it was theorized that nanoparticles could also be separated according to 
size and shape.158 Hanauer et al. separated silver and gold nanoparticles by size and shape 
successfully and analyzed the separated particles using UV-Vis and TEM. The bands 
elucidated a good separation according to shape and TEM confirmed that shape 
separation is possible for rod-shaped and spherical shaped GNPs.  
 
Using a Biorad preparatory gel rig, we performed a separation of GNPs and analyzed our 
success using UV-Vis and TEM. We see a large increase in the number of triangular gold 
nanoplates after separation. Fractions were taken off the gel and the resulting GNP 
fractions were dissoluted with KCN and lyophilized. The fractions were extracted with 
organic solvent to remove salts and analyzed using MS. 
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Cyanide Permeability of Gold Nanoprism Edges 
4.1 – Thiol 
 
Introduction 
Cyanide leaching has been used in mining since 1887 for the extraction of gold.159 
Cyanide forms a linear gold complex and allows it to become water soluble, giving 
feasibility to extracting gold from the ore. The process uses oxygen as well as seen by 
 
4Au + 8NaCN + O2 + 2H2O → 4Na[Au(CN)2] + 4NaOH 
 
Nanoparticle synthesis from naturally occurring lipids are fitting due to the diversity of 
their chemical structures. The lipids have advantages over other complexes of forming 
complex three-dimensional structures, being available from renewable food stocks and 
allowing for an inexpensive source of the complexes, such as soy.160,166 Nanoparticles 
synthesized from the natural lipids have the added advantage of acting as models for cell 
membrane interactions161 and are useful as likely biocompatible probes.162 
 
Stability of GNPs is especially important when using the nanoparticles in biological 
systems.166 Any aggregation of the particles can lead to adverse effects in the bio-system. 
The stability of GNPs has been studied extensively in both organic-soluble163 and water-
soluble systems.166 To improve stability of these GNPs, hybrid capping agents have been 
employed such as alkanethiols,166 which act both as an anchor for the lipids and as a 
protectorant for areas of high curvature on the GNP. This is similar to the role 
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alkanethiols play in two-dimensional hybrid bilayers164 as well as in tethered bilayer lipid 
membrane systems.165 
 
This makes cyanide ideal for testing the protective capability of capping ligands on GNPs 
in aqueous solutions. We report here on the use of cyanide in the stability of soy lecithin 
as well as the stability of a soy lecithin/decanethiol hybridized capping agent. 
 
4.2 – Experimental 
 
L-α-Phosphatidylcholine Type IV-S ≥ 30% TLC (PC30), L-ascorbic acid, potassium 
cyanide and 1-decanethiol were purchased from Aldrich. Hydrogen tetrabromoaurate (III) 
hydrate was purchased from Strem Chemicals Inc. Sodium borohydride (98%) was 
purchased from J.T. Baker.  Milli-Q H2O was used at 18.1 mΩ resistance. Centrifugation 
was performed on a Beckman Optima LE-80K Ultracentrifuge equipped with a SW65K 
swinging bucket rotor at 4000 rpm (1592 x g RCF). 
 
Preparation of bromide derived gold seed using PC30 
Gold bromide seed solution was also synthesized fresh prior to each experiment.  Briefly, 
PC30 stock (1 mL) diluted to 5 mL with milliQ H2O was added to a vial and while 
vigorously stirring, aqueous HAuBr4 . xH2O (10 mM, 125 µL) was added followed by 
immediate addition of NaBH4aq (10 mM, 600 µL). The resulting purple seed solution was 
allowed to react 45 min to one hour prior to use. 
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Preparation of growth solutions with HAuBr4 
A typical bromide growth solution was prepared by diluting PC30 stock (2 mL) with H2O 
(15 mL). To this was added aqueous HAuBr4 . xH2O (10 mM, 400 µL), bromide derived 
lecithin gold seed (40 µL). The resulting orange solution was vigorously stirred and a 
rapid addition of ascorbic acid (100 mM, 40 µL) was immediately performed. The 
solution immediately became transparent and then began to darken to a darker red/purple 
within 5 min.  The resulting solution was allowed to react 18 h prior to analysis. 
 
Preparation of decanethiol 
Decanethiol was prepared by dissolving 1-decanethiol (20.6 µL) in 95% ethanol (1 mL) 
to make a 100 mM solution. A 10 µM solution was prepared similarly. Both 
concentrations of 1-Decanethiol were added to separate 1 mL aliquots of GNP growth 
solution and UV-Vis taken while stirring gently. 
 
 
Preparation of KCN 
KCN was prepared freshly and used within 24 hours of preparation. KCN (200 mg) was 
dissolved in mQ H2O (10 mL) to make a 307 mM solution. 10 µL was added to each 
solution of GNP growth solution and GNP/1-decanethiol hybrid solution respectively (@ 
1 mL each). The dissociation of gold from the nanoparticle was monitored by UV-Vis 
over time. Spectra were taken at t=0 s, t=10 s and t=60 s while stirring gently. 
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Instruments 
Absorbance spectra are obtained on an Agilent 8453 UV-visible Spectrophotometer with 
a diode array using a 1.0 cm path length quartz cell and a magnetic stirring mechanism. 
 
TEM 
TEM images are acquired on a Tecnai F-20 FEI microscope. Images are collected at an 
acceleration voltage of 200 kV using a CCD detector.  Samples are prepared by drop 
casting (5	  µL) solutions of nanoparticles onto carbon-coated (300 Å) Formvar films on 
copper. Samples are dried for at least 1 h before images were obtained. For more dilute 
samples, multiple castings are performed on the same grid.  Nanoparticle size analysis 
and length to width aspect ratio are performed using ImageJ software after applying a 
band pass filter to the images and adjusting the threshold. 
 
4.3 Results and Discussion 
 
Previous work has been performed on spherical GNPs using several thiols as a stabilizing 
agent.166 Thiols have been shown to improve stability of nanoparticles by coordinating to 
any exposed gold surface such as edges and areas of high curvature. These areas of high 
curvature allow access to low cone angle detergents such as saturated thiols and this in 
turn lowers the strain energy of the PC bilayer around the curvature.166,167  
 
A simplified schematic is shown in Figure 4.1 showing thiol coverage on the surface of 
the GNPs while the organic tail groups are protected from the aqueous solution by the 
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soy lipid bilayer. Figure 4.1 also gives and example of two substances with differing cone 
angles. This affects the ability of the lipid to cover the surface of the nanoparticle due to 
ineffective packing of the lipids. High strain energies can be induced if capping agents 
with large cone angles are packed on a highly curved surface. 
 
 
 
Figure 4.1 – Schematic of thiol-hybridized liposome and the comparison of cone angle for the thiol versus 
the phospholipid component of the lecithin 
 
Using 1-decanethiol as a co-capping agent, we tested several concentrations of thiol to 
determine the stability of the GNPs to cyanide leaching. This was monitored by UV-
Visible spectroscopy at several time increments. Figure 4.2 shows a series of spectra 
obtained by adding KCN to a simple growth solution. We see that the soy lecithin does 
not give full coverage of the surface of the nanoparticles as is demonstrated by the loss of 
the red-shifted plasmon absorption signal and the greatly decreased intensity of the blue-
shifted plasmon band within a minute. 
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Figure 4.2 – Addition of KCN to 1 mL of our PC growth solution. Time increments are at 0, 10 and 60 
seconds. The red-shifted plasmon intensity decreases showing the inability of PC to provide protection to 
the anisotropic nanoparticles whereas the blue-shifted intensity does decrease, but never disappears 
 
The blue-shifted plasmon band does not completely disappear, even after 24 hours so 
there are some particles that do have complete coverage and are resistant to CN etching. 
TEM were taken of the remaining solution of particles and these are seen in Figure 4.3, 
which reveals that the nanoparticles are extremely small (< 10 nm). 
 
 
 
Figure 4.3 – TEM of particles remaining 4 hours after cyanide etching of the growth solution.  
Particle sizes are < 10 nm. 
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First, 100 mM 1-decanethiol was added to a gold growth solution until the UV-Vis shows 
a slight formation of aggregates (occurred at 9 µL). This creates a saturated thiol solution 
with an overall thiol concentration of 890 µM. This ensures that all exposed surface 
should be covered in thiol. The aggregation occurring is believed to be due to the 
exchange of phospholipid with thiol and causing them to fall out of solution from reduced 
solubility. This also causes an initial intensity drop when thiol is added as seen in Figure 
4.4. 
 
 
Figure 4.4 – UV-Vis spectra of PC growth solution with (orange trace) and without (red trace) 1-
decanethiol added 
To test the stability of the resulting hybrid nanoparticles, KCN was added and the 
solution was monitored by UV-Vis. Figure 4.5 shows the resulting UV-Vis spectral 
series. 
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Figure 4.5 – Thiol hybridized GNPs before (red) and after addition of KCN. 
 
We can see in Figure 4.5 that no decrease in intensity occurs after the initial addition of 
the KCN. The stability of the nanoparticles is such that after 24 hours, the solution still 
gives a UV-Vis signal showing both plasmon bands (Figure 4.5, green trace). In order to 
test the stability of the different shapes seen in the PC growth solution, we added 20 µL 
of 10 mM thiol solution giving a final concentration of 200 µM. When we add cyanide to 
this solution, we find that there is an initial drop in intensity that continues for 30 
minutes. We see that after 2 minutes, the red-shifted plasmon band disappears completely 
and the blue-shifted plasmon band remains even after 30 minutes. As seen with the PC 
sample above, this is indicative of spherical particles surviving the leaching process. 
Figure 4.6 shows the progression of the λmax for both the red-shifted and blue-shifted 
plasmon bands. 
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b)  
 
Figure 4.6 – a) UV-Vis showing progression of hybrid nanoparticles after cyanide addition. Each trace is a 
1-minute time increment. b) This graph shows the value of the λmax for both the red-shifted (red trace) and 
blue-shifted (blue trace) plasmon bands 
 
Figure 4.6 shows that the prismatic nanoparticles are much less stable to cyanide etching 
than the spherical nanoparticles in our solution. The red-shifted plasmon band disappears 
within 2 minutes while the blue-shifted plasmon band remains for multiple days. It is 
believed that the high area of curvature on the edge of our prismatic nanoparticles and the 
chemical makeup of the lipids on the edge allow easy access for cyanide, even with thiol 
addition. High strain energy of the lipids is associated with the high amount of curvature 
on the GNPs. This can be alleviated using alkane thiol. In spherical GNPs, we think that 
the alkyl group of 1-decanethiol excludes a volume of lipid from the inner leaflet, thereby 
reducing the strain energy associated with a highly curved lipid layer.168  However, in a 
a) 
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prismatic GNP, the bilayer coverage of the prismatic nanoparticle’s edge does not seem 
to be complete and even with thiol as a stabilizing agent, the gold surface remains 
exposed (Figure 4.7).  
 
       
Figure 4.7 – Schematic showing degree of curvature of lipids on a prism’s edge versus a spherical 
nanoparticle’s edge. The degree of curvature of a prism’s edge is much sharper leaving more room between 
the lipid’s inner layer for cyanide penetration.  
 
Conclusion 
We’ve shown the dependence of 1-decanethiol concentration on the stability of prismatic 
and spherical GNPs. It is seen that at lower concentrations, the edges of the prismatic 
GNPs are exposed to KCN attack and dissociate within minutes. This can be useful in 
explaining the stability and effectiveness of these nanoparticles in when used in the 
design of biosensors as well as providing a method of etch resists for gold 
micropatterning. Additionally, this data can help contribute to our understanding of how 
these systems can be used for drug delivery. 
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Conclusions and Recommendations for Future Work 
The work presented in my dissertation describes the synthesis, analysis, purification and 
modification of a prismatic gold nanoparticle for potential use in biological systems. 
Using soybean lecithin and HAuBr4 in a seed mediated synthesis produced a mixed 
population of prismatic gold nanoparticles and spherical gold nanoparticles, which could 
be separated using gel electrophoresis and analyzed using mass spectrometry. 
Phosphatidic acid was found to be responsible in part for the shape control of the GNPs 
and the stability of the GNPs in water was achieved and improved upon using thiol 
addition. The experiments discussed in this thesis have led to new insights in gold 
nanoparticle growth. 
 
Conclusion 1 
Growth conditions are important when considering shape control of GNPs in an aqueous 
environment. Halide composition showed us that bromide salts of gold were found to be 
critical in shape control of GNPs. When titrating bromide salt into a growth solution 
containing soy lecithin and HAuCl4, the growth of a NIR plasmon band is revealed. 
Substituting HAuBr4 enhances the NIR plasmon band to a local maximum absorption. 
The ligand source was also shown to be critical in GNP growth. While, PC30 shows 
anisotropic growth, PC95 reveals the phosphatidylcholine is not the responsible ligand for 
shape control. PC95 also reduced the stability of GNPs in solution, causing aggregation 
almost immediately after synthesis, however, PC30 allows for stability of GNPs for 
multiple months following synthesis. 
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Conclusion 2 
Gel electrophoresis was the most effective means of size and shape separation of GNPs 
available to us. Using a gel prep column, we could partially separate our prismatic GNPs 
from the larger part of the spherical GNPs. TEM analysis of the prismatic GNPs shows 
an average size of 94 nm and that the GNPs are single crystalline. UV-vis shows the final 
fractions giving a λmax at 865 nm. Leaching the gold using KCN and extracting the 
ligands allowed analysis using MS and identification of phosphatidic acid as a potential 
shape-directing ligand. Upon spiking PC95 (known not to give anisotropic GNPs) with 
PA, it was indeed found that a NIR plasmon band grows into the UV-Vis. This is also the 
first instance of synthesis of anisotropic GNPs using PA that we have found. 
 
Future Work 
A more efficient separation of the shapes of GNPs would allow for a more detailed 
analysis of the surface ligands found on the prismatic GNPs. This would in turn lead to a 
more efficient synthesis of prismatic GNPs and maximize the yield of prismatic GNPs. 
Possible solutions to the separation problem would be to increase the length of the gel 
column and decrease the voltage to allow more time to separate. Other techniques such as 
membrane permeation and nanofiltration were not extensively pursued and are also 
viable separation techniques. 
More PA titration experiments are currently under way. As the limited time and limited 
amount of PA in the lab prevented us from including that work in the dissertation, it is 
still being studied for publication.  
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Conclusion 3 
Stability of GNPs is paramount when considering their use in biological systems. The 
biological environment contains a large array of components that could lead to 
degradation or aggregation of GNPs in the system. In adding small amounts of 
decanethiol to the GNPs, we found that we could study the stability of the GNPs to 
cyanide etching. It was found that at 5 µM concentration of decanethiol, both the 
spherical and prismatic GNPs were completely impermeable to cyanide. If the 
concentration of thiol was lowered to 2 µM, the prismatic GNPs were found to lose their 
stability to cyanide while the spherical GNPs retained their protection. This experiment 
led to a better understanding of the ligand coverage on the surface of the different shapes 
of GNP. It is postulated that the coverage of soy ligand on the edge of the prismatic 
GNPs is not sufficient to prevent permeation of cyanide to the gold surface. However, a 
sufficient amount of decanethiol prevents this permeation allowing for a possible 
protective barrier when introduced into a biological system. 
 
Future work 
These experiments were done prior to our work in the separation of the GNPs. A more 
uniform population of prismatic GNPs would allow us to get a better idea of what is 
occurring at the gold surface and also allow us to compare different shapes and sizes of 
GNPs to cyanide etching both with and without thiol. This work also shows potential in 
allowing a specific shape to be leached and the ligand content of those shapes to be 
analyzed by MS. In other words, if we stabilize only the spherical GNPs to cyanide and 
dissolve the prismatic GNPs, the free ligand’s content in solution could be analyzed and 
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provide another method for the identity of shape-directing ligands. 
	   77	  
References 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Faulkner,	  Raymond	  Oliver	  (1962).	  A	  Concise	  Dictionary	  of	  Middle	  Egyptian	  (11th	  ed.).	  Oxford,	  United	  Kingdom:	  Griffith	  Institute.	  p.	  129.	  2	  W.	  Ostwald	  (1917)	  An	  Introduction	  to	  Theoretical	  and	  Applied	  Colloid	  Chemistry.	  John	  Wiley	  &	  Sons,	  Inc.	  New	  York.	  3	  P.C.	  Ray	  (1903).	  History	  of	  Hindu	  Chemistry,	  The	  Bengal	  Chemical	  and	  
Pharmaceutical	  Works.	  Calcutta.	  4	  British	  Museum,	  http://www.britishmuseum.org/explore/highlights/highlight_objects/pe_mla/t/the_lycurgus_cup.aspx	  5	  Harden	  D.B.	  and	  Toynbee	  J.M.C.	  (1959)	  The	  Rothschild	  Lycurgus	  Cup.	  Archaeologia,	  Vol.	  97.	  6	  Susan	  Frank	  (1982).	  Glass	  and	  Archaeology.	  London.	  7	  Kunckle,	  Johann	  (1679).	  Ars	  vitraria	  experimentalis,	  oder,	  Vollkommene	  Glasmacher-­‐Kunst	  (Documenta	  technica)	  (German	  Edition).	  Brandenburg.	  8	  Michael	  Faraday,	  Philos.	  Trans.	  R.	  Soc.	  London,	  1857,	  147,	  145.	  9	  R.	  Zsigmondy.	  (1917).	  The	  Chemistry	  of	  Colloids,	  John	  Wiley	  &	  Sons,	  Inc.,	  New	  York.	  10	  R.	  Zsigmondy.	  (1909)	  Colloids	  and	  the	  Ultramicroscope.	  John	  Wiley	  &	  Sons,	  Inc.	  New	  York.	  11	  Zsigmondy,	  R.	  Huckel,	  E.	  Zeitschrift	  Fur	  Physikalische	  Chemie—Stochiometrie	  Und	  
Verwandtschaftslehre.	  1925,	  116,	  291.	  12	  R.	  Zsigmondy,	  Colloids	  and	  the	  Ultramicroscope,	  John	  Wiley	  &	  Sons,	  Inc.,	  New	  York,	  1909.	  13	  T.	  Svedberg.	  (1921)	  The	  Formation	  of	  Colloids.	  D.	  Van	  Nostrand	  Company,	  Inc.	  New	  York.	  14	  T.	  Svedberg,	  A.	  Tiselius.	  (1928)	  Colloid	  Chemistry,	  The	  Chemical	  Catalog	  Company,	  Inc.	  New	  York.	  15	  T.	  Svedberg,	  K.O.	  Pedersen.	  (1940)	  The	  Ultracentrifuge,	  Oxford	  University	  Press.	  Oxford.	  
	   78	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  16	  Chanda	  N.,	  Kan	  P.,	  Watkinson	  L.,	  Shukla	  R.,	  Zambre	  A.,	  Carmack	  T.,	  Engelbrecht	  H.,	  Lever	  J.,	  Katti	  K.,	  Fent	  G.,	  Casteel	  S.,	  Smith	  C.	  J.,	  Miller	  W.,	  Jurisson	  S.,	  Boote	  E.,	  Robertson	  D.,	  Cutler	  C.,	  Dobrovolskaia	  M.,	  Kannan	  R.,	  Katti	  K.	  V.	  Nanomedicine,	  
2010,	  6,	  201.	  17	  Corma,	  A.,	  Garcia,	  H.	  Chem.	  Soc.	  Rev.,	  2008,	  37,	  2096.	  18	  Hasobe,	  T.,	  Imahori,	  H.,	  Kamat,	  P.	  V.,	  Ahn,	  T.	  K.,	  Kim,	  S.	  K.,	  Kim,	  D.,	  Fujimoto,	  A.,	  Hirakawa,	  T.,	  Fukuzumi,	  S.	  J.	  Am.	  Chem.	  Soc.,	  2005,	  127,	  1216.	  19	  Kean,	  W.	  F.	  Kean,	  I.	  R.	  L.	  Inflammopharmacology,	  2008,	  16,	  112.	  20	  Wiegleb,	  J.	  C.	  (1777).	  Historisch-­‐Kritische	  Untersuchung	  Der	  Alchemie.	  Zental-­‐Antiquarit,	  Der	  Deutschen	  Demokratischen	  Republik,	  Leipzig.	  21	  The	  New	  Jerusalem	  Bible.	  Ed.	  Susan	  Jones.	  New	  York:	  Doubleday,	  1985.	  Print.	  Exodus	  32:20.	  22	  Waley,	  A.	  (1956).	  The	  Way	  and	  Its	  Power:	  A	  Study	  of	  the	  Tao	  Teaching	  and	  its	  place	  
in	  Chinese	  Thought.	  Allen	  and	  Unwin,	  London.	  23	  Fung,	  Y.	  L.	  (1952).	  A	  History	  of	  Chinese	  Philosophy.	  Translated	  by	  Derk	  Bodde.	  Vol.	  1,	  Ch	  8.	  24	  Garrison	  F.	  H.	  (1966)	  Introduction	  to	  the	  History	  of	  Medicine,	  4th	  ed.	  Philadelphia:	  W.	  B.	  Saunders,	  112.	  25	  Hunt,	  L.	  B.	  Ambix.,	  1979,	  26,	  221.	  26	  Koch,	  R.	  Deutsche	  medinische	  Wochenschrift,	  1890	  16,	  756.	  27	  Forestier,	  J.	  Annales	  de	  medicine	  Intern	  Societe	  medical	  Des	  Hopitaux	  de	  Paris	  
Bulletins	  et	  Memoires,	  1930,	  54,	  272.	  28	  Giljohann,	  D.	  A.,	  Seferos,	  D.	  S.,	  Daniel,	  W.	  L.,	  Massich,	  M.	  D.,	  Patel,	  P.	  C.	  Mirkin,	  C.	  A.	  
Angew.	  Chem.	  Int.	  Ed.,	  2010,	  49,	  3280.	  29	  Huang,	  X.	  Jain,	  P.	  K.,	  El-­‐Sayed,	  I.	  H.,	  El-­‐Sayed,	  M.	  A.	  Lasers	  Med.	  Sci.,	  2008,	  23,	  217.	  30	  Ah,	  C.	  S.,	  Hong,	  S.	  D.,	  Jang,	  D.	  J.	  Phys.	  Chem.	  B,	  2001,	  105,	  7871.	  31	  Huang,	  X.,	  El-­‐Sayed,	  I.	  H.	  Qian,	  W.El-­‐Sayed,	  M.	  A.	  J.	  Am.	  Chem.	  Soc.,	  2006,	  128,	  2115.	  32	  Cherukuri,	  P.,	  Glazer,	  E.	  S.,	  Curley,	  S.	  A.	  Adv.	  Drug	  Delivery	  Rev.,	  2010,	  62,	  339.	  
	   79	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  33	  Alkilany,	  A.	  M.,	  Thompson,	  L.	  B.,	  Boulos,	  S.	  P.,	  Sisco,	  P.	  N.,	  Murphy,	  C.	  J.	  Adv.	  Drug	  
Delivery	  Rev.,	  2012,	  64,	  190.	  34	  Lin,	  K.	  Y.,	  Bagley,	  A.	  F.,	  Zhang,	  A.	  Y.,	  Karl,	  D.	  L.,	  Yoon,	  S.	  S.,	  Bhatia,	  S.	  N.	  Nano	  LIFE,	  
2010,	  1,	  277.	  35	  Sekhon,	  B.	  S.	  J.	  Pharm.	  Sci.,	  2012,	  2,	  14.	  36	  Huff,	  T.	  B.,	  Tong,	  L.,	  Zhao.	  Y.,	  Hansen,	  M.	  N.,	  Cheng,	  J.,	  Wei,	  A.	  Nanomedicine,	  2007,	  
2,	  125.	  37	  El-­‐Sayed,	  I.	  H.,	  Huang,	  X.,	  El-­‐Sayed,	  M.	  A.	  Cancer	  Letters,	  2006,	  239,	  129.	  38	  Rai,	  A.,	  Singh,	  A.,	  Ahmad,	  A.,	  Sastry,	  M.	  Langmuir,	  2006,	  22,	  736.	  39	  Hirsch,	  L.	  R.,	  Stafford,	  R.	  J.,	  Bankson,	  J.	  A.,	  Sershen,	  S.	  R.,	  Rivera,	  B.,	  Price,	  R.	  E.,	  Hazle,	  J.	  D.,	  Halas,	  N.	  J.,	  West,	  J.	  L.	  PNAS,	  2003,	  100,	  13549.	  40	  Shankar,	  S.	  S.,	  Rai,	  A.,	  Ankamwar,	  B.,	  Singh,	  A.,	  Ahmad,	  A.,	  Sastry,	  M.	  Nat.	  Mat.,	  
2004,	  3,	  482.	  41	  Au,	  L.,	  Zheng,	  D.	  Zhou,	  F.,	  Li,	  Z.,	  Li,	  X.,	  Xia,	  Y.	  ACS	  Nano,	  2008,	  2,	  1645.	  42	  Hurst,	  S.	  J.,	  Payne,	  E.	  K.,	  Qin,	  L.,	  Mirkin,	  C.	  A.	  Angew.	  Chem.,	  Int.	  Ed.	  2006,	  45,	  2672.	  43	  Jin,	  R.,	  Cao,	  Y.,	  Mirkin,	  C.	  A.,	  Kelly,	  K.	  L.,	  Schatz,	  G.	  C.,	  Zheng,	  J.	  G.	  Science	  2001,	  294,	  1901.	  44	  Millstone,	  J.	  E.,	  Park,	  S.,	  Shuford,	  K.	  L.,	  Qin,	  L.,	  Schatz,	  G.	  C.,	  Mirkin,	  C.	  A.	  J.	  Am.	  Chem.	  
Soc.	  2005,	  127,	  5312.	  45	  Tao,	  A.	  R.,	  Habas,	  S.,	  Yang,	  P.	  Small	  2008,	  4,	  310.	  46	  Xia,	  Y.,	  Xiong,	  Y.,	  Lim,	  B.,	  Skrabalak,	  S.	  E.	  Angew.	  Chem.,	  Int.	  Ed.	  2009,	  48,	  60.	  47	  Zhou,	  K.,	  Li,	  Y.	  Ibid.2012,	  51,	  602.	  48	  Somorjai,	  G.	  A.,	  Frei,	  H.,	  Park,	  J.	  Y.	  J.	  Am.	  Chem.	  Soc.	  2009,	  131,	  16589.	  49	  Giljohann,	  D.	  A.,	  Seferos,	  D.	  S.,	  Daniel,	  W.	  L.,	  Massich,	  M.	  D.,	  Patel,	  P.	  C.,	  Mirkin,	  C.	  A.	  
Angew.	  Chem.,	  Int.	  Ed.	  2010,	  49,	  3280.	  50	  Yu,	  Y.,	  Chang,	  S.,	  Lee,	  C.,	  Wang,	  C.	  R.	  C.	  J.	  Phys.	  Chem.	  B	  1997,	  101,	  6661.	  51	  Mohamed,	  M.	  B.,	  Ismail,	  K.	  Z.,	  Link,	  S.,	  El-­‐Sayed,	  M.	  A.	  J.	  Phys.	  Chem.	  B,	  1998,	  102,	  9370.	  52	  Jana,	  N.	  R.,	  Gearheart,	  L.,	  Murphy,	  C.	  J.	  Chem.	  Mater.	  2001,	  13,	  2313.	  
	   80	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  53	  Jena	  B.	  K.,	  Raj	  C.	  R.	  J.	  Phys.	  Chem.	  C	  2007,	  111,	  15146.	  54	  Nehl,	  C.	  L.,	  Liao,	  H.,	  Hafner,	  J.	  H.	  Nano	  Lett.,	  2006,	  6,	  683.	  55	  Grzelczak,	  M.,	  Perez-­‐Juste,	  J.,	  Mulvaney,	  P.,	  Liz-­‐Marzan,	  L.	  M.	  Chem.	  Soc.	  Rev.,	  2008,	  
37,	  1783.	  56	  Liu,	  M.	  	  P.	  Guyot-­‐Sionnest.	  J.	  Phys.	  Chem.	  B.,	  2005,	  109,	  22192.	  57	  Gole,	  A.,	  Murphy,	  C.J.	  Chem.	  Mater.,	  2004,	  16,	  3633.	  58	  Perez-­‐Juste,	  J.,	  Pastoriza-­‐Santos.	  L.	  M.,	  Liz-­‐Marzan,	  L.	  M.,	  Mulvaney,	  P.	  	  Coord.	  
Chem.	  Rev.,	  2005,	  249,	  1870.	  59	  Ha,	  T.	  H.,	  Koo,	  H.	  J.,	  Chung,	  B.	  H.	  J.	  Phys.	  Chem.	  C.	  2007,	  111,	  1123.	  60	  Millstone,	  J.	  E.;	  Wei,	  W.;	  Jones,	  M.	  R.;	  Yoo,	  H.;	  Mirkin,	  C.	  A.	  Nano	  Lett.	  2008,	  8,	  2526.	  61	  Smith,	  D.	  K.,	  Miller,	  N.,	  Korgel,	  B.	  A.	  Langmuir,	  2009,	  25,	  9518.	  62	  Gou,	  L.,	  Murphy,	  C.	  J.	  Chem.	  Mater.,	  2005,	  17,	  3668.	  63	  Millstone,	  J.	  E.,	  Hurst,	  S.	  J.,	  Metraux,	  G.	  S.,	  Cutler,	  J.	  I.,	  Mirkin	  ,C.	  A.	  Small,	  2009,	  5,	  646.	  64	  Yu,	  C.,	  Varghese,	  L.,	  Irudayaraj,	  J.	  Langmuir	  2007,	  23,	  9114.	  65	  Takahashi,	  H.,	  Niidome,	  Y.,	  Niidome,	  T.,	  Kaneko,	  K.,	  Kawasaki,	  H.,	  Yamada,	  S.	  
Langmuir	  2006,	  22,	  2.	  66	  Connor,	  E.	  E.,	  Mwamuka,	  J.,	  Gole,	  A.,	  Murphy,	  C.	  J.,	  Wyatt	  M.	  D.	  Small,	  2005,	  1,	  325.	  	  67	  Cortesi,	  R.,	  Esposito,	  E.,	  Menegatti,	  E.,	  Gambari,	  R.,	  Nastruzzi,	  C.	  Int.	  J.	  Pharm.,	  
1996,	  139,	  69.	  	  68	  Mirska,	  D.,	  Schirmer,	  K.,	  Funari,	  S.	  S.,	  Langner,	  A.,	  Dobner,	  B.,	  Brezesinski,	  G.	  
Colloids	  Surf.	  B,	  2005,	  40,	  51.	  69	  Lozano,	  N.,	  Al-­‐Jamal,	  W.	  T.,	  Taruttis,	  A.,	  Beziere,	  N.,	  Burton,	  N.	  C.,	  Van	  den	  Bossche,	  J.,	  Mazza,	  M.,	  Herzog,	  E.,	  Ntziachristos,	  V.,	  Kostarelos,	  K.	  J.	  Am.	  Chem.	  Soc.,	  2012,	  
134,	  13256.	  70	  Zhang,	  W.,	  Qiao,	  X.,	  Chen,	  J.	  Mat.	  Sci.	  Eng.	  B,	  2007,	  142,	  1.	  71	  Wijaya,	  A.,	  Schaffer,	  S.	  B.,	  Pallares,	  I.	  G.,	  Hamad-­‐Schifferli,	  K.	  ACS	  Nano,	  2009,	  3,	  80.	  72	  Huang,	  X.,	  Jain,	  P.	  K.,	  El-­‐Sayed,	  I.	  H.,	  El-­‐Sayed,	  M.	  A.	  Lasers	  in	  Medical	  Science	  2008,	  
23,	  217.	  
	   81	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  73	  Sarkar,	  P.	  K.,	  Chaudhary,	  A.	  K.	  J.	  Sci.	  Ind.	  Res.,	  2010,	  69,	  901.	  74	  H.	  Tait	  (ed.),	  Five	  thousand	  years	  of	  glass	  (London,	  The	  British	  Museum	  Press,	  1991)	  75	  Neetu,	  S.,	  Anand,	  C.	  Int.	  J.	  Res.	  Pharm.,	  2012,	  3,	  5.	  	  76	  Frens,	  G.	  Nature	  1973,	  241,	  20.	  77	  Turkevich,	  J.,	  Hillier,	  J.,	  Stevenson,	  P.	  C.	  Disc.	  Farad.	  Soc.	  1951,	  11,	  55.	  78	  Wilcoxon,	  J.	  P.,	  Williamson,	  R.	  L.,	  Baughman,	  R.	  J.	  Chem.	  Phys.	  1993,	  98,	  9933.	  79	  Brust,	  M.,	  Walker,	  M.,	  Bethell,	  D.,	  Schiffrin,	  D.	  J.,	  Whyman,	  R.	  J.	  Chem.	  Soc.,	  Chem.	  
Commun.	  1994,	  801.	  80	  Schutt,	  E.	  G.	  Eur.	  Patent	  Application	  90317671.4,	  filed	  September	  25,	  1990.	  81	  Brown,	  K.	  R.,	  Walter,	  D.	  G.,	  Natan,	  M.	  J.	  Chem.	  Mater.	  2000,	  12,	  306.	  82	  Lawn,	  R.	  J.,	  Brun,	  W.	  A.	  Crop	  Sci.,	  1974,	  14,	  11.	  83	  Yamabe,	  S.,	  Kaneko,	  K.,	  Inoue,	  H.,	  Takita,	  T.	  Biosci.	  Biotechnol.	  Biochem.,	  2004,	  68,	  250.	  84	  Chan,	  J.	  M.,	  Zhang,	  L.,	  Yuet,	  K.	  P.,	  Liao,	  G.,	  Rhee,	  J.,	  Langer,	  R.,	  Farokhzad,	  O.	  C.	  
Biomaterials,	  2009,	  30,	  1627.	  85	  Morse,	  W.J.	  Yearbook	  of	  agriculture,	  1918,	  USDA,	  Washington,	  D.C.,	  101.	  86	  Makoto	  Suzuki,	  M.D.,	  Bradley	  J.	  Willcox,	  M.D.,	  and	  D.	  Craig	  Willcox,	  Ph.D.	  “The	  Okinawa	  Centenarian	  Study,”	  1997,	  http://okicent.org/study.html.	  87	  Tanito,	  M.,	  Brush,	  R.	  S.,	  Elliott,	  M.	  H.,	  Wicker,	  L.	  D.,	  Henry,	  K.	  R.,	  Anderson,	  R.	  E.	  J.	  
Lipid	  Res.,	  2009,	  50,	  807.	  88	  Smithers,	  L.	  G.,	  Gibson,	  R.	  A.,	  McPhee,	  A.,	  Makrides,	  M.	  Am	  J	  Clin	  Nutr,	  2008,	  88,	  1049.	  89	  Quella,	  S.	  K.,	  Loprinzi,	  C.	  L.,	  Barton,	  D.	  L.,	  Knost,	  J.	  A.,	  Sloan,	  J.	  A.,	  LaVasseur,	  B.	  I.,	  Swan,	  D.,	  Krupp,	  K.	  R.,	  Miller,	  K.	  D.,	  Novotny,	  P.	  J.,	  J.	  Clin.	  Onc.,	  2000,	  18,	  1068.	  90	  Clarkson,	  T.	  B.,	  J.	  Nutr.,	  2002,	  132,	  5665.	  91	  Guetta,	  V.,	  Quyyumi,	  A.	  A.,	  Prasad,	  A.,	  Panza,	  J.	  A.,	  Waclawiw,	  M.,	  Cannon,	  R.	  O.	  III	  
Circulation,	  1997,	  96,	  2795.	  92	  Palmer,	  R.	  M.	  J.,	  Ferrige,	  A.	  G.,	  Moncada,	  S.	  Nature,	  1987,	  327,	  524.	  
	   82	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  93	  Vaz,	  C.,	  van	  Doeveren,	  P.	  F.	  N.	  M.,	  Reis,	  R.	  L.,	  Cunha,	  A.	  M.	  Biomacromolecules,	  2003,	  
4,	  1520.	  94	  Zema,	  L.,	  Loreti,	  G.,	  Melocchi,	  A.,	  Maroni,	  A.,	  Gazzaniga,	  A.	  J.	  Control	  Release,	  2012,	  
159,	  324.	  95	  Abdekhodaie,	  M.	  J.,	  Liu,	  Z.,	  Erhan,	  S.	  Z.	  and	  Wu,	  X.	  Y.,	  Polym.	  Int.,	  2012	  ,	  DOI	  10.1002/pi.4244	  96	  Silva,	  S.	  S.,	  Santos,	  M.	  I.,	  Coutinho,	  O.	  P.,	  Mano,	  J.	  F.,	  Reis,	  R.	  L.	  J.	  Mater.	  Sci.	  Mater.	  
Med.,	  2005,	  16,	  575.	  97	  Henglein,	  A.	  J.	  Phys.	  Chem.	  1993,	  97,	  8457.	  98	  Henglein,	  A.	  Chem.	  Rev.	  1989,	  89,	  1861.	  99	  Alivisatos,	  A.	  P.	  J.	  Phys.	  Chem.	  1996,	  100,	  13226.	  100	  Schmid,	  G.	  Clusters	  Colloids:	  From	  Theory	  to	  Application,	  VCH:  	  Weinheim,	  1994.	  101	  Papavassiliou,	  G.	  C.	  Prog.	  Solid	  State	  Chem.	  1980,	  12,	  185.	  102	  Perenboom,	  J.	  A.	  A.	  J.,	  Wyder,	  P.,	  Meier,	  P.	  Phys.	  Rep.	  1981,	  78,	  173.	  103	  Hughes,	  A.	  E.,	  Jain,	  S.	  C.	  Adv.	  Phys.	  1979,	  28,	  717.	  104	  Kerker,	  M.	  The	  Scattering	  of	  Light	  and	  Other	  Electromagnetic	  Radiation,	  Academic	  Press:  	  New	  York,	  1969.	  105	  Bohren,	  C.	  F.,	  Huffman,	  D.	  R.	  Absorption	  and	  Scattering	  of	  Light	  by	  Small	  Particles,	  Wiley:  	  New	  York,	  1983.	  106	  Creighton,	  J.	  A.,	  Eadon,	  D.	  G.	  J.	  Chem.	  Soc.,	  Faraday	  Trans.	  1991,	  87,	  3881.	  107	  Mulvaney,	  P.	  Langmuir	  1996,	  12,	  788.	  108	  Brus,	  L.	  E.	  Appl.	  Phys.	  A	  1991,	  53,	  465.	  109	  C.	  J.	  Murphy.	  Nanocubes	  and	  Nanoboxes.	  Science,	  298:2139–2141,	  2002.	  110	  National	  Institute	  of	  Health	  http://publications.nigms.nih.gov/chemhealth/cool.htm	  111	  Finkelstein,	  N.P.,	  Hancock,	  R.D.	  Gold	  Bull.,	  1974,	  7,	  72.	  112	  R.	  J.	  Puddephatt.	  The	  Chemistry	  of	  Gold.	  Elsevier,	  1978.	  113	  Baschand,	  H.,	  Gray,	  H.B.	  Inorg.	  Chem.,	  1967,	  6,	  365.	  
	   83	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  114	  Miessler,	  G.	  L.,	  Tarr,	  D.	  A.	  Inorganic	  Chemistry,	  4th	  ed.,	  Prentice	  Hall:	  Upper	  Saddle	  River,	  2011.	  115	  Mason,	  W.R.,	  Gray,	  H.B.	  J.	  Am.	  Chem.	  Soc.,	  1968,	  90,	  5721.	  116	  Eustis,	  S.	  PhD.	  Dissertation,	  Georgia	  Institute	  of	  Technology,	  2006.	  117	  D.	  J.	  Shaw.	  Introduction	  to	  Colloid	  and	  Surface	  Chemistry.	  Butterworths,	  3rd	  edition,	  1989.	  118	  H.-­‐F.	  Eicke.	  Modern	  Trends	  of	  Colloid	  Science	  in	  Chemistry	  and	  Biology,	  Birkhäuser	  Verlag,	  Basel,	  1985.	  119	  Mie,	  G.	  Annalen	  Der	  Physik,	  1908,	  25,	  377.	  120	  U.	  Kreibig	  and	  M.	  Vollmer.	  Optical	  Properties	  of	  Metal	  Clusters,	  1995,	  25.	  Springer,	  Berlin.	  121	  C.	  F.	  Bohren	  and	  D.	  R.	  Huffman.	  Absorption	  and	  Scattering	  of	  Light	  by	  Small	  
Particles.	  1983,	  Wiley,	  New	  York.	  122	  C.	  Kittel.	  Introduction	  to	  Solid	  State	  Physics.	  1966,	  John	  Wiley	  &	  Sons,	  Inc.,	  third	  edition.	  123	  R.	  E.	  Dodd.	  Chemical	  Spectroscopy.	  1962,	  Elsevier,	  New	  York.	  124	  Mulvaney,	  P.	  Langmuir,	  1996,	  12,	  788.	  125	  Link,	  S.,	  El-­‐Sayed,	  M.A.	  J.	  Phys.	  Chem.	  B,	  1999,	  103,	  4212.	  126	  Kreibig,	  U.,	  Fragstein,	  C.V.	  Z.	  Phys.,	  1969,	  224,	  307.	  127	  van	  der	  Zande,	  B.M.I.,	  Böhmer,	  M.R.,	  Fokkink,	  L.G.J.,	  Schönenberger,	  C.	  Langmuir,	  
2000,	  16,	  451.	  128	  Gans,	  R.	  Annalen	  Der	  Physik,	  1912,	  37,	  881.	  129	  Zheng,	  J.,	  Zhang,	  C.,	  Dickson,	  R.M.	  Phys.	  Rev.	  Lett.,	  2004,	  93,	  077402.	  130	  Link,	  S.,	  El-­‐Sayed,	  M.A.	  J.	  Phys.	  Chem.	  B,	  1999,	  103,	  3073.	  131	  Link,	  S.,	  El-­‐Sayed,	  M.A.	  J.	  Phys.	  Chem.	  B,	  1999,	  103,	  8410.	  132	  Nikoobakht,	  B.,	  El-­‐Sayed,	  M.A.	  Chem.	  Mater.,	  2003,	  15,	  1957.	  133	  Percz-­‐Juste,	  J.,	  Pastoriza-­‐Santos,	  I.,	  Liz-­‐Marzán,	  L.	  M.,	  Mulvaney,	  P.	  Coord.	  Chem.	  
Rev.,	  2005,	  249,	  1870.	  134	  Yu,	  C.,	  Varghese,	  L.,	  Irudayaraj,	  J.	  Langmuir	  2007,	  23,	  9114.	  
	   84	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  135	  Nune,	  S.,	  Chanda,	  N.,	  Shukla,	  R.,	  Katti,	  K.,	  Kulkarni,	  R.	  R.,	  Thilakavathy,	  S.,	  Mekapothula,	  S.,	  Kannan,	  R.,	  Katti,	  K.	  J.	  Mater.	  Chem.,	  2009,	  19,	  2912.	  136	  Markowitz,	  M.A.,	  Dunn,	  D.N.,	  Chow,	  G.M.,	  Zhang,	  J.	  J.	  Colloid	  Interface	  Sci.	  1999,	  
210,	  73.	  137	  Pileni,	  M.P.	  Nat.	  Mat.,	  2003,	  2,	  145.	  138	  Regev,	  O.,	  Backov,	  R.,	  Faure,	  C.	  Chem.	  Mater.,	  2004,	  16,	  5280.	  139	  A.	  Bose,	  J.	  Sarkar	  Nanostructured	  Materials	  for	  Advanced	  	  	  	  	  	  Transportation	  Applications.	  Report	  to	  University	  of	  Rhode	  Island,	  URITC	  Project	  No.	  000464,	  	  Kingston,	  RI	  02881,	  2001.	  140	  Bell,	  F.	  P.	  Prog.	  Lipid	  Res.,	  1978,	  7,	  207.	  141	  Dawidowicz,	  E.	  A.	  Curro	  Top.	  Membr.	  Transp.,	  1987,	  29,	  175.	  142	  Kaplan,	  M.	  R	  .,	  Simoni,	  R.	  D.	  Cell	  Bioi.,	  1985,	  101,	  441.	  143	  Kaplan,	  M.	  R	  .,	  Simoni,	  R.	  D.	  Cell	  Bioi.,	  1985,	  101,	  446.	  144	  Vance,	  E.	  Biochim.	  Biophys.	  Acta.,	  1988,	  963,	  10.	  145	  Wirtz,	  K.	  W.	  A.	  Annu.	  Rev.	  Biochem.,	  1991,	  60,	  73.	  146	  Alper,	  J.,	  Hamad-­‐Schifferli,	  K.	  Langmuir,	  2010,	  26,	  3786.	  147	  Chithrani,	  B.	  D.,	  Ghazani,	  A.	  A.,	  Chan,	  W.	  C.	  W.	  Nano	  Lett.,	  2006,	  6,	  662.	  148	  Dai,	  Q.,	  Coutts,	  J.,	  Zou,	  J.,	  Huo,	  Q.	  Chem.	  Commun.,	  2008,	  44,	  2858.	  149	  Hiramatsu,	  H.,	  Osterloh,	  F.	  E.	  Chem.	  Mater.,	  2004,	  16,	  2509.	  150	  Chen,	  H.	  M.,	  Liu,	  R.,	  Asakura,	  K.,	  Jang,	  L.,	  Lee,	  J.	  J.	  Phys.	  Chem.	  C,	  2007,	  111,	  18550.	  151	  Johnson,	  C.	  J.,	  Dujardin,	  E.,	  Davis,	  S.	  A.,	  Murphy,	  C.	  J.,	  Mann,	  S.	  J.	  Mater.	  Chem.	  
2002,	  12,	  1765.	  152	  Yu,	  C.	  X.,	  Varghese,	  L.,	  Irudayaraj,	  J.	  Langmuir,	  2007,	  23,	  9114.	  153	  Dai,	  Q.,	  Coutts,	  J.,	  Zou,	  J.,	  Huo,	  Q.	  Chem.	  Commun.,	  2008,	  25,	  2858.	  154	  Huang,	  X.,	  El-­‐Sayed,	  I.	  H.,	  Qian,	  W.,	  El-­‐Sayed,	  M.	  A.	  J.	  Am.	  Chem.	  Soc.,	  2006,	  128,	  2115.	  155	  Jie	  An	  Yang,	  J.,	  Murphy,	  C.J.	  Langmuir,	  2012,	  28,	  5404.	  156	  Lofton,	  C.,	  Sigmund	  W.	  Adv.	  Funct.	  Mater.,	  2005,	  15,	  1197.	  157	  a)	  Kryndushkin	  D.	  S.,	  Alexandrov	  I.	  M.,	  Ter-­‐Avanesyan	  M.	  D.,	  Kushnirov	  V.	  V.	  
	   85	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Journal	  of	  Biological	  Chemistry,	  2003,	  278,	  49636.	  b)	  J.	  Sambrook,	  D.	  W.	  Russel	  Molecular	  Cloning:	  A	  Laboratory	  Manual	  3rd	  Ed.	  Cold	  Spring	  Harbor	  Laboratory	  Press.	  Cold	  Spring	  Harbor,	  NY.,	  2001.	  c)	  J.	  M.	  Berg,	  J.	  L.	  Tymoczko,	  L.	  Stryer	  Biochemistry	  5th	  ed.	  WH	  Freeman,	  2002.	  158	  Hanauer,	  M.,	  Pierrat,	  S.,	  Zins,	  I.,	  Lotz,	  A.,	  Sönnichsen,	  C.	  Nano	  Lett.,	  2007,	  7,	  2881.	  159	  Habashi,	  F.	  Recent	  Advances	  in	  Gold	  Metallurgy,	  Revisa	  de	  la	  Facultad	  de	  
Ingeniera,	  Universidad	  Central	  de	  Venezuela	  1998,	  13,	  	  43.	  160	  Mackiewicz,	  M.	  R.,	  Ayres,	  B.	  R.,	  Reed,	  S.M.	  Nanotechnology,	  2008,	  19,	  115607.	  161	  Loftus,	  A.	  F.,	  Reighard,	  K.	  P.,	  Kapourales,	  S.	  A.,	  Leopold,	  M.	  C.	  J.	  Am.	  Chem.	  Soc.,	  
2008,	  130,	  1649.	  162	  Fan,	  H.,	  Leve,	  E.	  W.,	  Scullin,	  C.,	  Gabaldon,	  J.,	  Tallant,	  D.,	  Bunge,	  S.,	  Boyle,	  T.,	  Wilson,	  M.	  C.,	  Brinker,	  C.	  J.	  Nano	  Lett.,	  2005,	  5,	  645.	  163	  a)	  Daniel,	  M.	  Astruc,	  D.	  Chem.	  Rev.,	  2004,	  104,	  293.	  b)	  Paulini,	  R.,	  Frankamp,	  B.	  L.,	  Rotello,	  V.	  M.	  Langmuir,	  2002,	  18,	  2368.	  164	  a)	  Plant,	  A.	  Langmuir,	  1999,	  15,	  5128,	  b)	  Brevnov,	  D.	  A.,	  Finklea,	  H.O.	  Langmuir,	  
2000,	  16,	  5973.	  165	  a)	  Cornell,	  B.	  A.,	  Braach-­‐Maksvytis,	  V.	  L.	  B.,	  King,	  L.	  G.,	  Osman,	  P.	  D.	  J.,	  Raguse,	  B.,	  Wieczorek,	  L.,	  Pace,	  R.	  J.	  Nature,	  1997,	  387,	  580,	  b)	  He,	  L.,	  Robertson,	  J.	  W.	  F.,	  Li,	  J.,	  Kärcher,	  I.,	  Schiller,	  S.	  M.,	  Knoll,	  W.,	  Naumann,	  R.	  Langmuir,	  2005,	  21,	  11666,	  c)	  Köper,	  I.	  Mol.	  BioSyst.,	  2007,	  3,	  651.	  166	  a)	  Sitaula,	  S.,	  Mackiewicz,	  M.	  R.,	  Reed,	  S.	  M.	  Chem.	  Commun.,	  2008,	  44,	  3013.	  b)	  Jana,	  N.	  R.,	  Gearheart,	  L.,	  Obare,	  S.	  O.,	  Murphy,	  C.	  J.	  Langmuir,	  2002,	  18,	  922.	  c)	  Rodr	  ́ıguez-­‐Ferna	  ́ndez,	  J.,	  Pe	  ́rez-­‐Juste,	  J.,	  Mulv-­‐	  aney,	  P.,	  Liz-­‐Marza	  ́n,	  L.	  M.	  J.	  Phys.	  
Chem.	  B,	  2005,	  109,	  14257.	  167	  Szule,	  J.	  A.,	  Fuller,	  N.	  L.,	  Rand,	  R.	  P.	  Biophys.	  J.,	  2002,	  83,	  977.	  168	  Zimmerberg,	  J.,	  Kozlov,	  M.	  M.	  Nat.	  Rev.	  Mol.	  Cell	  Biol.,	  2006,	  7,	  9.	  
